{"content":"<li class=\"n-box-item date-title\" data-end=\"1474948799\" data-start=\"1474862400\" data-txt=\"Sunday, December 22, 2019\">Monday, September 26, 2016</li><li class=\"n-box-item sa-box-item\" data-id=\"3210917\" data-ts=\"1474941305\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210917-futures-turn-green-during-debate\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Futures turn green during debate</a></h4><ul>\n<li>We'll leave it to others to decipher, but U.S. stock index futures - marginally in the red ahead of the presidential debate - have been climbing since the festivities got underway about 50 minutes ago.</li>\n<li>S&amp;P 500 futures are now <font color=\"green\">up 0.35%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210917\" data-linked=\"Futures turn green during debate\" data-tweet=\"Futures turn green during debate https://seekingalpha.com/news/3210917-futures-turn-green-during-debate?source=tweet\" data-url=\"https://seekingalpha.com/news/3210917-futures-turn-green-during-debate\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>42&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210913\" data-ts=\"1474932069\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CEL\" target=\"_blank\">CEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210913-cellcom-wraps-tender-for-debentures\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cellcom wraps tender for debentures</a></h4><ul>   <li>Cellcom (<a href=\"https://seekingalpha.com/symbol/CEL\" title=\"Cellcom Israel, Ltd.\">CEL</a> <font color=\"red\">-4.2%</font>) today wrapped a public tender of debentures that it announcd yesterday.</li>    <li>The telecom got offers for about 1.2B shekels (about $320.2M) worth, and accepted only \"a portion\" of the offers.</li>    <li>Final pricing came to about 103M shekels of series J debentures at 2.45% interest, sold at par value (and linked to the Israeli CPI); and about 304M shekels of Series K debentures, at 3.55% interest, sold at par.</li>    <li>Total net consideration to Cellcom is about 402.97M shekels ($107.5M).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3210913\" data-linked=\"Cellcom wraps tender for debentures\" data-tweet=\"$CEL - Cellcom wraps tender for debentures https://seekingalpha.com/news/3210913-cellcom-wraps-tender-for-debentures?source=tweet\" data-url=\"https://seekingalpha.com/news/3210913-cellcom-wraps-tender-for-debentures\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210910\" data-ts=\"1474929496\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NAVB\" target=\"_blank\">NAVB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210910-navidea-names-goldberg-new-ceo-boosts-rowinsky-to-chairmans-seat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Navidea names Goldberg new CEO, boosts Rowinsky to chairman&#39;s seat</a></h4><ul>   <li>Navidea Biopharmaceuticals (<a href=\"https://seekingalpha.com/symbol/NAVB\" title=\"Navidea Biopharmaceuticals\">NAVB</a> <font color=\"red\">-3.9%</font>) has named Dr. Michael Goldberg its new president and chief executive officer.</li>    <li>Goldberg will vacate his role as chairman of the board, but retain his board seat. The company's named Dr. Eric Rowinsky as its new chairman.</li>       <li>Goldberg has been on the board since November 2013 and had served as interim CEO for several months in 2014. He was previously chairman and CEO at Emisphere Technologies.</li>    <li>Rowinsky has been on Navidea's board since July 2010, and is currently executive chairman and president at Rgenix.</li>    <li>\"At this important transition point for the Company, we will benefit greatly from [Goldberg's] expertise as we drive the development of our Manocept clinical immunodiagnostic and immunotherapeutic programs to deliver targeted products to improve patient outcomes,\" Rowinsky says.</li>    <li>After hours: <a href=\"https://seekingalpha.com/symbol/NAVB\" title=\"Navidea Biopharmaceuticals\">NAVB</a> <font color=\"green\">+4.1%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3210910\" data-linked=\"Navidea names Goldberg new CEO, boosts Rowinsky to chairman&#39;s seat\" data-tweet=\"$NAVB - Navidea names Goldberg new CEO, boosts Rowinsky to chairman&#39;s seat https://seekingalpha.com/news/3210910-navidea-names-goldberg-new-ceo-boosts-rowinsky-to-chairmans-seat?source=tweet\" data-url=\"https://seekingalpha.com/news/3210910-navidea-names-goldberg-new-ceo-boosts-rowinsky-to-chairmans-seat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210906\" data-ts=\"1474927966\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RDCM\" target=\"_blank\">RDCM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210906-nfv-start-up-radcomplus-6-to-10-year-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NFV start-up Radcom +6% to 10-year high</a></h4><ul>   <li>Micro-cap Israeli networking tech company Radcom (NASDAQ:<a href=\"https://seekingalpha.com/symbol/RDCM\" title=\"Radcom Ltd.\">RDCM</a>) <font color=\"green\">rose 6%</font> today to a 10-year high, still in the glow of a <a href=\"http://www.investors.com/news/technology/tiny-radcom-still-boosted-by-att-endorsement-soars-to-10-year-high/\" target=\"_blank\">flattering mention as a \"key supplier\"</a> by AT&amp;T, according to Needham.</li>    <li>Needham raised its price target to $23 from $17 after meeting with Radcom chief Yaron Ravkaie yesterday; that target implies 19% upside from Friday's close.</li>        <li>Radcom's in trials with nine other possible service-provider customers, and those new customers are \"likely to kick in as revenue drivers in the back half of (2017).\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3210906\" data-linked=\"NFV start-up Radcom +6% to 10-year high\" data-tweet=\"$RDCM - NFV start-up Radcom +6% to 10-year high https://seekingalpha.com/news/3210906-nfv-start-up-radcomplus-6-to-10-year-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3210906-nfv-start-up-radcomplus-6-to-10-year-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210900\" data-ts=\"1474926178\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWX\" target=\"_blank\">TWX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210900-magnificent-seven-remake-leads-in-slow-film-weekend\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">&#39;Magnificent Seven&#39; remake leads in slow film weekend</a></h4><ul>   <li>Another slow weekend for films ended with a remake of <i>The Magnificent Seven</i> (<a href=\"https://seekingalpha.com/symbol/SNE\" title=\"Sony Corporation\">SNE</a> <font color=\"red\">-0.4%</font>) topping the box office by beating some animated counter-programming.</li>    <li>Sony's new take on the Western grossed $34.7M to top the week's other wide debut, <i>Storks</i> (<a href=\"https://seekingalpha.com/symbol/TWX\" title=\"Time Warner Inc.\">TWX</a> <font color=\"red\">-0.8%</font>), which drew $21.3M. Both films edged last week's leader, <i>Sully</i> (NYSE:<a href=\"https://seekingalpha.com/symbol/TWX\" title=\"Time Warner Inc.\">TWX</a>), which fell to third with $13.5M. It's grossed $92.1M domestically in its three weeks of release.</li>    <li>Sequel <i>Bridget Jones's Baby</i> (<a href=\"https://seekingalpha.com/symbol/CMCSA\" title=\"Comcast Corporation\">CMCSA</a> <font color=\"red\">-2%</font>) fell off in its second weekend, dropping to No. 4 with just $4.7M.</li>    <li>\n<i>Storks</i> is the second film for recently assembled Warner Animation Group, after <i>The LEGO Movie.</i>\n</li>    <li>Among longer-running high grossers still in theaters: <i>Suicide Squad</i> (<a href=\"https://seekingalpha.com/symbol/TWX\" title=\"Time Warner Inc.\">TWX</a>) was No. 8 with $3.1M (cumulative domestic of $318.1M; worldwide total of $731.8M); <i>Pete's Dragon</i> (<a href=\"https://seekingalpha.com/symbol/DIS\" title=\"The Walt Disney Company\">DIS</a> <font color=\"red\">-1.4%</font>) was No. 13 with $870K (cumulative domestic of $74.2M; worldwide total of $122.4M); <i>The Secret Life of Pets</i> (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CMCSA\" title=\"Comcast Corporation\">CMCSA</a>) was No. 15 with $692K (cumulative domestic of $364.3M; worldwide total of $820.9M).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3210900\" data-linked=\"&#39;Magnificent Seven&#39; remake leads in slow film weekend\" data-tweet=\"$TWX $TWX $CMCSA - &#39;Magnificent Seven&#39; remake leads in slow film weekend https://seekingalpha.com/news/3210900-magnificent-seven-remake-leads-in-slow-film-weekend?source=tweet\" data-url=\"https://seekingalpha.com/news/3210900-magnificent-seven-remake-leads-in-slow-film-weekend\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210899\" data-ts=\"1474925777\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210899-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li>\n<b>Top gainers, as of 5.25 p.m.:</b> <a href=\"https://seekingalpha.com/symbol/KITE\" title=\"Kite Pharma\">KITE</a> <font color=\"green\">+9.6%</font>. <a href=\"https://seekingalpha.com/symbol/SNX\" title=\"SYNNEX Corporation\">SNX</a> <font color=\"green\">+7.0%</font>. <a href=\"https://seekingalpha.com/symbol/JUNO\" title=\"Juno Therapeutics\">JUNO</a> <font color=\"green\">+6.2%</font>. <a href=\"https://seekingalpha.com/symbol/ARRY\" title=\"Array BioPharma Inc.\">ARRY</a> <font color=\"green\">+5.1%</font>. <a href=\"https://seekingalpha.com/symbol/BLCM\" title=\"Bellicum Pharmaceuticals\">BLCM</a> <font color=\"green\">+3.4%</font>.</li>\n<li>\n<b>Top losers, as of 5.25p.m.:</b> <a href=\"https://seekingalpha.com/symbol/NAT\" title=\"Nordic American Tankers Limited\">NAT</a> <font color=\"red\">-5.6%</font>. <a href=\"https://seekingalpha.com/symbol/RICE\" title=\"Rice Energy Inc\">RICE</a> <font color=\"red\">-4.2%</font>. <a href=\"https://seekingalpha.com/symbol/MYOK\" title=\"MyoKardia\">MYOK</a> <font color=\"red\">-3.65%</font>. <a href=\"https://seekingalpha.com/symbol/MPW\" title=\"Medical Properties Trust, Inc.\">MPW</a> <font color=\"red\">-3.3%</font>. <a href=\"https://seekingalpha.com/symbol/MT\" title=\"ArcelorMittal\">MT</a> <font color=\"red\">-2.7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3210899\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$KITE $SNX $JUNO - After Hours Gainers / Losers https://seekingalpha.com/news/3210899-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3210899-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210892\" data-ts=\"1474923990\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NAT\" target=\"_blank\">NAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210892-nordic-american-tanker-to-launch-11m-share-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nordic American Tanker to launch 11M-share offering</a></h4><ul>     <li>Nordic American Tanker (NYSE:<a href=\"https://seekingalpha.com/symbol/NAT\" title=\"Nordic American Tankers Limited\">NAT</a>) <font color=\"red\">-5.9%</font> AH after announcing a 11M-share public offering, with an underwriters option to purchase up to an additional 1.65M common shares.</li>     <li>NAT says it is reserving 100K shares to be purchased by Chairman and CEO Herbjorn Hansson and 400K shares to be purchased by Vice Chairman Andreas Ugland.</li>\n<li>NAT says it plans to use the proceeds of the offering primarily to finance the expansion of its fleet and for general corporate purposes.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210892\" data-linked=\"Nordic American Tanker to launch 11M-share offering\" data-tweet=\"$NAT - Nordic American Tanker to launch 11M-share offering https://seekingalpha.com/news/3210892-nordic-american-tanker-to-launch-11m-share-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3210892-nordic-american-tanker-to-launch-11m-share-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210885\" data-ts=\"1474923219\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SXL\" target=\"_blank\">SXL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210885-sunoco-logistics-to-buy-vitols-permian-basin-assets-for-760m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sunoco Logistics to buy Vitol&#39;s Permian Basin assets for $760M</a></h4><ul>     <li>Sunoco Logistics Partners (NYSE:<a href=\"https://seekingalpha.com/symbol/SXL\" title=\"Sunoco Logistics Partners, L.P.\">SXL</a>) <font color=\"red\">-3.3%</font> AH after agreeing to acquire Vitol's Permian Basin crude oil unit for $760M plus working capital.</li>     <li>SXL says the acquisition will provide a ~2M-barrel crude oil terminal in Midland, Tex., a crude oil gathering and mainline pipeline system in the Midland Basin, including a significant acreage dedication, and crude oil inventories related to Vitol\u2019s crude oil purchasing and marketing business in west Texas.</li>\n<li>In connection with the deal, Energy Transfer Partners (ETP) and Energy Transfer Equity (ETE),  as the owners of SXL general partner Sunoco Partners, will reduce incentive distributions by $60M over a two-year  period.</li>\n<li>To help fund the deal, SXL announces a 21M-unit public offering, with an underwriters option to purchase up to 3.15M additional common units.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3210885\" data-linked=\"Sunoco Logistics to buy Vitol&#39;s Permian Basin assets for $760M\" data-tweet=\"$SXL $SXL $ET - Sunoco Logistics to buy Vitol&#39;s Permian Basin assets for $760M https://seekingalpha.com/news/3210885-sunoco-logistics-to-buy-vitols-permian-basin-assets-for-760m?source=tweet\" data-url=\"https://seekingalpha.com/news/3210885-sunoco-logistics-to-buy-vitols-permian-basin-assets-for-760m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210873\" data-ts=\"1474921806\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KITE\" target=\"_blank\">KITE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210873-kite-pharmas-lead-product-candidate-shows-impressive-efficacy-in-phase-1-2-study-shares-up-14\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kite Pharma&#39;s lead product candidate shows impressive efficacy in Phase 1/2 study; shares up 14% after hours</a></h4><ul>\n<li>Top-line results from a Phase 1/2 clinical trial, ZUMA-1, assessing Kite Pharma's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/KITE\" title=\"Kite Pharma\">KITE</a>) lead product candidate KTE-C19 in patients with diffuse large B-cell lymphoma (DLBCL) who failed to respond to chemo showed an objective response rate (ORR) of 76%, including 47% complete remissions (CR).</li>\n<li>ZUMA-1 had two cohorts, #1 included patients with DLBCL and #2 enrolled patients with transformed follicular lymphoma (TFL) and primary mediastinal B-cell lymphoma (PMBCL).</li>\n<li>The ORR and CR for DLBCL in Phase 1 (n=7) were 71% and 57%, respectively. In Phase 2 the rates for DLBCL (n=51) were 76% and 47%, respectively. In patients with TFL/PMBCL (n=11), the rates were 91% and 73% respectively. At Month 3 the rates in Phase 1 were 43% and 43%, respectively. The rates at Month 3 in Phase 2 for each group were 39%, 33%, 64% and 64%, respectively. At Months 6 and 9, the Phase 1 rates were 43% and 43%, respectively. The data are pending for the Phase 2 groups.</li>\n<li>Across the 62 subjects in Phase 2, the most common serious adverse events (Grade 3 or higher) were neutropenia (66%), anemia (40%), febrile neutropenia (29%), thrombocytopenia (29%) and encephalopathy (26%). The rates of Grade 3 or higher cytokine release syndrome (CRS) and neurological toxicity were 18% and 34%, respectively. Two patients died from KTE-C19-related events (cardiac arrest and an overactive immune condition called hemophagocytic lymphohistiocytosis, both associated with CRS).</li>\n<li>Kite plans to pursue regulatory approval in DLBCL, TFL and PMBCL.</li>\n<li>Additional data will be submitted for presentation at a future scientific meeting. The primary analysis of 101 patients, including six-month follow-up data, should be available in Q1 2017.</li>\n<li>Management will host a conference call starting momentarily to discuss the data.</li>\n<li>Shares are up <font color=\"green\">14%</font> after hours on increased volume.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210873\" data-linked=\"Kite Pharma&#39;s lead product candidate shows impressive efficacy in Phase 1/2 study; shares up 14% after hours\" data-tweet=\"$KITE - Kite Pharma&#39;s lead product candidate shows impressive efficacy in Phase 1/2 study; shares up 14% after hours https://seekingalpha.com/news/3210873-kite-pharmas-lead-product-candidate-shows-impressive-efficacy-in-phase-1-2-study-shares-up-14?source=tweet\" data-url=\"https://seekingalpha.com/news/3210873-kite-pharmas-lead-product-candidate-shows-impressive-efficacy-in-phase-1-2-study-shares-up-14\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210868\" data-ts=\"1474921109\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MPW\" target=\"_blank\">MPW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210868-medical-properties-trust-makes-1_25b-acquisition\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Medical Properties Trust makes $1.25B acquisition</a></h4><ul>\n<li>The company agrees to buy nine acute care hospitals operated by Steward Health Care System (owned by Cerberus), with $1.2B for the hospital real estate and a $50M equity investment in Steward making up the $1.25B price tag.</li>\n<li>After accounting for previously disclosed sales of about $800M, and another $300M of previously disclosed and pending acquisitions of German hospitals, <a href=\"https://seekingalpha.com/symbol/MPW\" title=\"Medical Properties Trust, Inc.\">MPW</a> expects per share accretion of 10%.</li>\n<li>As part of the deal, MPW has the right of first refusal for future Steward hospitals.</li>\n<li>Alongside the purchase announcement, the company is selling 33.5M shares, with underwriter greenshoe of 5.025B shares.</li>\n<li>Shares <font color=\"red\">-1.9%</font> after hours</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210868\" data-linked=\"Medical Properties Trust makes $1.25B acquisition\" data-tweet=\"$MPW - Medical Properties Trust makes $1.25B acquisition https://seekingalpha.com/news/3210868-medical-properties-trust-makes-1_25b-acquisition?source=tweet\" data-url=\"https://seekingalpha.com/news/3210868-medical-properties-trust-makes-1_25b-acquisition\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210867\" data-ts=\"1474921039\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/THO\" target=\"_blank\">THO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210867-thor-beats-0_24-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Thor beats by $0.24, beats on revenue</a></h4><ul>\n<li>Thor (NYSE:<a href=\"https://seekingalpha.com/symbol/THO\" title=\"Thor Industries, Inc.\">THO</a>): FQ4 EPS of $1.57 <font color=\"green\">beats by $0.24</font>.</li>\n<li>Revenue of $1.29B (+21.7% Y/Y) <font color=\"green\">beats by $20M</font>.</li>\n<li>Shares <font color=\"green\">+2.1%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210867\" data-linked=\"Thor beats by $0.24, beats on revenue\" data-tweet=\"$THO - Thor beats by $0.24, beats on revenue https://seekingalpha.com/news/3210867-thor-beats-0_24-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3210867-thor-beats-0_24-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210865\" data-ts=\"1474920976\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNX\" target=\"_blank\">SNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210865-synnex-beats-0_17-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Synnex beats by $0.17, beats on revenue</a></h4><ul>\n<li>Synnex (NYSE:<a href=\"https://seekingalpha.com/symbol/SNX\" title=\"SYNNEX Corporation\">SNX</a>): FQ3 EPS of $1.73 <font color=\"green\">beats by $0.17</font>.</li>\n<li>Revenue of $3.67B (+10.2% Y/Y) <font color=\"green\">beats by $180M</font>.</li>\n<li>Shares <font color=\"green\">+2.5%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210865\" data-linked=\"Synnex beats by $0.17, beats on revenue\" data-tweet=\"$SNX - Synnex beats by $0.17, beats on revenue https://seekingalpha.com/news/3210865-synnex-beats-0_17-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3210865-synnex-beats-0_17-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210851\" data-ts=\"1474919045\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBIM\" target=\"_blank\">GBIM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210851-globeimmune-up-33-on-hope-of-good-news-regarding-hbv-therapeutic-vaccine-liver-meeting\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GlobeImmune up 33% on hope of good news regarding HBV therapeutic vaccine at  Liver Meeting</a></h4><ul>\n<li>Thinly traded nano cap GlobeImmune (<a href=\"https://seekingalpha.com/symbol/GBIM\" title=\"GlobeImmune\">OTC:GBIM</a> <font color=\"green\">+33.3%</font>) perks up on <font color=\"green\">60% </font>higher volume, albeit on turnover of only 187K shares, as investors take positions ahead of <a href=\"http://www.aasld.org/events-professional-development/liver-meeting/presenters/abstracts\" target=\"_blank\">The Liver Meeting</a> in Boston, November 11 - 15.</li>\n<li>An oral abstract has been selected for presentation in Parallel Session 35 on GS-4774, a therapeutic HBV vaccine candidate being developed by Gilead Sciences (<a href=\"https://seekingalpha.com/symbol/GILD\" title=\"Gilead Sciences, Inc.\">GILD</a> <font color=\"red\">-0.9%</font>). Bulls perceive that acceptance of the paper, \"Safety and Efficacy of GS-4774 in Combination with TDF in Patients with Chronic Hepatitis B not on Antiviral Medication,\" bodes well for long-term (Week 48) positive results from the current <a href=\"https://clinicaltrials.gov/ct2/show/NCT02174276?term=gs-4774&amp;rank=2\" target=\"_blank\">Phase 2 trial</a>. Results at Week 24 fell short of expectations.</li>\n<li>\n<a href=\"https://www.globeimmune.com/infectious-disease/gs-4774/\" target=\"_blank\">GS-4774</a> is a therapeutic vaccine designed to generate T cell immune responses against hepatitis B virus (HBV) antigen-containing cells. It is being developed for use with antivirals with the aim of increasing the cure rate in patients with chronic HBV infection.</li>\n<li>Gilead inked a <a href=\"http://www.gilead.com/news/press-releases/2011/10/gilead-and-globeimmune-announce-license-and-collaboration-agreement--to-develop-therapeutic-vaccine-products-for-treatment-of-chronic--hepatitis-b-infection\" target=\"_blank\">license and collaboration deal </a>with GlobeImmune in October 2011 to develop therapeutic vaccine products for use in conjunction with Viread (tenofovir disoproxil fumarate/TDF).</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210851\" data-linked=\"GlobeImmune up 33% on hope of good news regarding HBV therapeutic vaccine at  Liver Meeting\" data-tweet=\"$GBIM $GBIM $GILD - GlobeImmune up 33% on hope of good news regarding HBV therapeutic vaccine at Liver Meeting https://seekingalpha.com/news/3210851-globeimmune-up-33-on-hope-of-good-news-regarding-hbv-therapeutic-vaccine-liver-meeting?source=tweet\" data-url=\"https://seekingalpha.com/news/3210851-globeimmune-up-33-on-hope-of-good-news-regarding-hbv-therapeutic-vaccine-liver-meeting\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>100&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210856\" data-ts=\"1474918989\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CCL\" target=\"_blank\">CCL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210856-shares-of-carnival-backtrack-despite-solid-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Carnival backtrack despite solid guidance</a></h4><ul>     <li>Carnival (<a href=\"https://seekingalpha.com/symbol/CCL\" title=\"Carnival Corporation\">CCL</a> <font color=\"red\">-1.4%</font>) trades lower in a volatile session after the company issued a solid FQ3 report and raised guidance. Volume on Carnival is more than 50% above normal activity.</li>     <li>The company's net revenue yield was up 2.7% during the quarter on a constant currency comparison. Lower fuel expenses and solid ticket prices underpinned the gain.</li>     <li>Full-year EPS guidance goes a range of $3.33 to $3.37, compared to a prior view from the cruise line operator of $3.25 to $3.35 and $3.34 consensus.</li>     <li>Previously: <a href=\"https://seekingalpha.com/news/3210742-carnival-beats-0_03-beats-revenue\" target=\"_blank\">Carnival beats by $0.03, beats on revenue</a> (Sept. 26)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3210856\" data-linked=\"Shares of Carnival backtrack despite solid guidance\" data-tweet=\"$CCL - Shares of Carnival backtrack despite solid guidance https://seekingalpha.com/news/3210856-shares-of-carnival-backtrack-despite-solid-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3210856-shares-of-carnival-backtrack-despite-solid-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210914\" data-ts=\"1474918931\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CWST\" target=\"_blank\">CWST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210914-casella-wasteplus-10-on-plan-for-potential-debt-refinancing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Casella Waste +10% on plan for potential debt refinancing</a></h4><ul>     <li>Casella Waste (<a href=\"https://seekingalpha.com/symbol/CWST\" title=\"Casella Waste Systems, Inc.\">CWST</a> <font color=\"green\">+10.7%</font>) is more than 10% higher on news of its proposed debt refinancing, consisting of a $150M revolving credit facility and $350M term loan B, the proceeds of which will be used to pay off its existing asset-backed lending facility and senior subordinated notes.</li>     <li>CWST also raises its adjusted EBITDA guidance for FY 2016 to $115M-$117M from a previous range of $111M-$115M, citing a strong pricing and operational performance during the first two months of Q3.</li>     <li>CWST reaffirms 2016 revenue guidance of $550M-$560M and established free cash flow guidance for the year at $20M-$24M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3210914\" data-linked=\"Casella Waste +10% on plan for potential debt refinancing\" data-tweet=\"$CWST - Casella Waste +10% on plan for potential debt refinancing https://seekingalpha.com/news/3210914-casella-wasteplus-10-on-plan-for-potential-debt-refinancing?source=tweet\" data-url=\"https://seekingalpha.com/news/3210914-casella-wasteplus-10-on-plan-for-potential-debt-refinancing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210854\" data-ts=\"1474918341\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRM\" target=\"_blank\">CRM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210854-twitter-reportedly-begins-process-to-evaluate-sale-m-speculation-recommences-updated\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Twitter reportedly begins process to evaluate sale as M&amp;A speculation recommences [updated]</a></h4><ul>\n<li>With Salesforce (reportedly working with Bank of America) (<a href=\"https://seekingalpha.com/symbol/CRM\" title=\"Salesforce.com, Inc.\">CRM</a> <font color=\"red\">-0.2%</font>), Alphabet (<a href=\"https://seekingalpha.com/symbol/GOOG/focus\" target=\"_blank\">GOOG</a>, <a href=\"https://seekingalpha.com/symbol/GOOGL/focus\" target=\"_blank\">GOOGL</a>) and <a href=\"https://seekingalpha.com/news/3210827-twitter-report-disney-mulling-bid-company\" target=\"_blank\">The Walt Disney Co.</a> (<a href=\"https://seekingalpha.com/symbol/DIS\" title=\"The Walt Disney Company\">DIS</a> <font color=\"red\">-1.3%</font>) rumored to be in the mix, Twitter (NYSE:<a href=\"https://seekingalpha.com/symbol/TWTR\" title=\"Twitter, Inc.\">TWTR</a>) is said to be <a href=\"http://www.bloomberg.com/news/articles/2016-09-26/disney-said-to-be-working-with-adviser-on-potential-twitter-bid\" target=\"_blank\">gearing up</a> to present itself to potential acquirers.</li>\n<li>While a bid by Salesforce is seen as unlikely and unfavorable by some (<a href=\"https://seekingalpha.com/news/3210596-citi-considers-twitter-salesforce-deal-unlikely\" target=\"_blank\">Citi</a>, <a href=\"https://seekingalpha.com/news/3210814-morgan-stanley-considers-salesforce-twitter-deal-probability-low\" target=\"_blank\">Morgan Stanley</a>), last Friday it <a href=\"https://seekingalpha.com/news/3210566-salesforces-vala-afshar-tweets-ambiguous-message-amid-twitter-takeover-speculation\" target=\"_blank\">appeared firmly in the mx</a>. Alphabet, meanwhile, is considered a <a href=\"http://www.recode.net/2016/9/14/12876560/twitter-acquisition-options-google-facebook-apple\" target=\"_blank\">favorite by others</a>, with the available cash, advertising expertise and social network tie-in possibilities to make Twitter work under a new parent organization. Now that Disney is the latest to reportedly join the group, sports, distribution and video prospects are <a href=\"https://seekingalpha.com/news/3210837-twitters-video-ambitions-give-disney-likely-acquisition-hook\" target=\"_blank\">being weighed</a>.</li>\n<li>Trading up more mildly than Friday's run on this development, it appears analysts, investors and <a href=\"http://www.bloomberg.com/news/articles/2016-09-25/twitter-bidders-vying-for-data-would-inherit-the-doldrums-too\" target=\"_blank\">Twitter itself</a> are unsure of what direction the company will take next. The negative reaction of Salesforce shares on Friday and Disney shares today, though, may signal difficulty in attaining favorable terms for all parties involved in a deal should one come closer to materialization.</li>\n<li>\n<strong>Update (3:41 PM ET)</strong>: CNBC's David Faber <a href=\"https://twitter.com/CNBCnow/status/780491700624101376\" target=\"_blank\">adds Microsoft</a> (<a href=\"https://seekingalpha.com/symbol/MSFT\" title=\"Microsoft Corporation\">MSFT</a> <font color=\"red\">-0.8%</font>) in as a potential bidder.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210854\" data-linked=\"Twitter reportedly begins process to evaluate sale as M&amp;A speculation recommences [updated]\" data-tweet=\"$CRM $CRM $DIS - Twitter reportedly begins process to evaluate sale as M&amp;A speculation recommences [updated] https://seekingalpha.com/news/3210854-twitter-reportedly-begins-process-to-evaluate-sale-m-speculation-recommences-updated?source=tweet\" data-url=\"https://seekingalpha.com/news/3210854-twitter-reportedly-begins-process-to-evaluate-sale-m-speculation-recommences-updated\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>81&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210855\" data-ts=\"1474918219\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TECK\" target=\"_blank\">TECK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210855-teck-seeks-environmental-ok-for-quebrada-blanca-copper-mine-expansion\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teck seeks environmental OK for Quebrada Blanca copper mine expansion</a></h4><ul>     <li>Teck Resources (TCK <font color=\"green\">+1.7%</font>) says it has requested  environmental approval for a phase two expansion project at its Quebrada Blanca copper mine in northern Chile.</li>\n<li>TCK says project optimization work currently underway targets capital costs of $4.5B-$5B with an initial mine life of 25 years, compared with a 2012 feasibility study  estimate of $5.6B.</li>     <li>TCK expects an updated feasibility study, including capital and operating cost estimates for the project, will be completed in Q1 2017, although it does not anticipate reaching a decision on whether to proceed with the project before mid-2018.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3210855\" data-linked=\"Teck seeks environmental OK for Quebrada Blanca copper mine expansion\" data-tweet=\"$TECK - Teck seeks environmental OK for Quebrada Blanca copper mine expansion https://seekingalpha.com/news/3210855-teck-seeks-environmental-ok-for-quebrada-blanca-copper-mine-expansion?source=tweet\" data-url=\"https://seekingalpha.com/news/3210855-teck-seeks-environmental-ok-for-quebrada-blanca-copper-mine-expansion\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210853\" data-ts=\"1474918209\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VIA\" target=\"_blank\">VIA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210853-ifr-after-downgrade-viacom-preparing-new-bond-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IFR: After downgrade, Viacom preparing new bond offering</a></h4><ul>   <li>Viacom (<a href=\"https://seekingalpha.com/symbol/VIA\" title=\"Viacom Inc.\">VIA</a> <font color=\"red\">-1.6%</font>, <a href=\"https://seekingalpha.com/symbol/VIAB\" title=\"Viacom Inc.\">VIAB</a> <font color=\"red\">-1.9%</font>) is <a href=\"http://www.reuters.com/article/us-viacom-bonds-idUSKCN11W227?feedType=RSS&amp;feedName=topNews&amp;utm_source=twitter&amp;utm_medium=Social\" target=\"_blank\">preparing a dollar-denominated bond offering</a> as soon as this week, IFR reports.</li>    <li>That move will gain some financial flexibility, and won't do anything to dampen reports that it may be considering a sale to CBS (CBS <font color=\"green\">+0.7%</font>), from which Viacom was split a decade ago.</li>    <li>BofA Merrill Lynch, Citigroup and Morgan Stanley are arranging investor calls for the bond tomorrow and Wednesday, the report said.</li>    <li>Despite some heavy leverage, the company has said it was planning to raise debt to fund its near-term maturities, Moody's says. That firm downgraded long-term debt ratings for Viacom on Thursday.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3210853\" data-linked=\"IFR: After downgrade, Viacom preparing new bond offering\" data-tweet=\"$VIA $VIA $VIAB - IFR: After downgrade, Viacom preparing new bond offering https://seekingalpha.com/news/3210853-ifr-after-downgrade-viacom-preparing-new-bond-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3210853-ifr-after-downgrade-viacom-preparing-new-bond-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210852\" data-ts=\"1474917984\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NLY\" target=\"_blank\">NLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210852-reits-working-on-down-day-for-major-averages\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">REITs working on down day for major averages</a></h4><ul>\n<li>A <font color=\"red\">1.55% decline</font> in Europe <a href=\"https://seekingalpha.com/news/3210842-deutsche-plunge-helps-send-money-flowing-government-paper\" target=\"_blank\">amid worries over </a>the financial condition of Deutsche Bank has helped send the U.S. averages <font color=\"red\">lower by 0.85%</font>, and Treasury yields to their slimmest this month. At the short end, traders are cutting bets on the chance of a rate hike at any point in 2016.</li>\n<li>Fading that negative action are the REITs, with the Vanguard REIT Index Fund (NYSEARCA:<a href=\"https://seekingalpha.com/symbol/VNQ\" title=\"Vanguard Real Estate ETF\">VNQ</a>) <font color=\"green\">higher by 0.3%</font> and the iShares U.S. Real Estate ETF (NYSEARCA:<a href=\"https://seekingalpha.com/symbol/IYR\" title=\"iShares U.S. Real Estate ETF\">IYR</a>) <font color=\"green\">up 0.2%</font>. The iShares Mortgage REIT ETF (BATS:<a href=\"https://seekingalpha.com/symbol/REM\" title=\"iShares Mortgage Real Estate Capped ETF\">REM</a>) is also <font color=\"green\">up 0.2%</font>.</li>\n<li>Among individual issues: Annaly Capital (<a href=\"https://seekingalpha.com/symbol/NLY\" title=\"Annaly Capital Management, Inc.\">NLY</a> <font color=\"green\">+0.8%</font>), American Capital Agency (<a href=\"https://seekingalpha.com/symbol/AGNC\" title=\"AGNC Investment Corp.\">AGNC</a> <font color=\"green\">+0.7%</font>), Realty Income (<a href=\"https://seekingalpha.com/symbol/O\" title=\"Realty Income Corporation\">O</a> <font color=\"green\">+1.1%</font>), Omega Healthcare (<a href=\"https://seekingalpha.com/symbol/OHI\" title=\"Omega Healthcare Investors, Inc\">OHI</a> <font color=\"green\">+1%</font>), HCP (<a href=\"https://seekingalpha.com/symbol/HCP\" title=\"HCP, Inc.\">HCP</a> <font color=\"green\">+0.8%</font>), Aimco (<a href=\"https://seekingalpha.com/symbol/AIV\" title=\"Apartment Investment &amp; Management Company\">AIV</a> <font color=\"green\">+1.7%</font>), Simon Property (<a href=\"https://seekingalpha.com/symbol/SPG\" title=\"Simon Property Group, Inc.\">SPG</a> <font color=\"green\">+0.5%</font>), Kimco (<a href=\"https://seekingalpha.com/symbol/KIM\" title=\"Kimco Realty Corporation\">KIM</a> <font color=\"green\">+0.8%</font>), Public Storage (<a href=\"https://seekingalpha.com/symbol/PSA\" title=\"Public Storage\">PSA</a> <font color=\"green\">+0.9%</font>), Stag Industrial (<a href=\"https://seekingalpha.com/symbol/STAG\" title=\"STAG Industrial, Inc.\">STAG</a> <font color=\"green\">+0.5%</font>)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210852\" data-linked=\"REITs working on down day for major averages\" data-tweet=\"$NLY $VNQ $IYR - REITs working on down day for major averages https://seekingalpha.com/news/3210852-reits-working-on-down-day-for-major-averages?source=tweet\" data-url=\"https://seekingalpha.com/news/3210852-reits-working-on-down-day-for-major-averages\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210850\" data-ts=\"1474917838\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SALE\" target=\"_blank\">SALE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210850-retailmenot-sinks-20-stifel-drops-to-sell\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RetailMeNot sinks 20% as Stifel drops to Sell</a></h4><ul>     <li>RetailMeNot (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SALE\" title=\"RetailMeNot, Inc.\">SALE</a>) has tanked today, <font color=\"red\">declining 20.3%</font> on triple normal volume, after Stifel Nicolaus dropped its rating to Sell, from Hold, amid declining traffic.</li>     <li>The firm has a price target of $9, which was about 20% downside from yesterday's close.</li>     <li>Desktop and mobile visits are likely declining, says analyst Scott Devitt, and they're <a href=\"http://www.streetinsider.com/Analyst+Comments/Stifel+Downgrades+RetailMeNot+Inc.+%28SALE%29+to+Sell/12068903.html\" target=\"_blank\">reducing revenue estimates</a> and core segment operating income estimates for Q3 as well as this fiscal year and next. \"Third-party data suggests [quarter-to-date] traffic has deteriorated from recent trends, versus our prior estimates which reflected an uptick from recent trends. Our new estimates are below consensus, though within guidance\" for Q3 and fiscal 2016.</li>     <li>The company's moving in the right direction operationally, he notes, but \"the path back to sustainable growth remains uncertain at this point and shares are discounting the risks from the transition to mobile.\" He's assuming core revenue growth of 1% in 2017 and \"the recent appreciation in shares is overextended given evidence of weaker current traffic trends and limited 2017 growth expectations.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3210850\" data-linked=\"RetailMeNot sinks 20% as Stifel drops to Sell\" data-tweet=\"$SALE - RetailMeNot sinks 20% as Stifel drops to Sell https://seekingalpha.com/news/3210850-retailmenot-sinks-20-stifel-drops-to-sell?source=tweet\" data-url=\"https://seekingalpha.com/news/3210850-retailmenot-sinks-20-stifel-drops-to-sell\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210845\" data-ts=\"1474916536\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210845-technology-top-5-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ACTA' title='Actua Corporation'>ACTA</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/MTLS' title='Materialise NV'>MTLS</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/EVBG' title='Everbridge'>EVBG</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/RDCM' title='Radcom Ltd.'>RDCM</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/DBD' title='Diebold Nixdorf'>DBD</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/HIMX' title='Himax Technologies, Inc.'>HIMX</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/INVE' title='Identiv, Inc.'>INVE</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/QUMU' title='Qumu Corporation'>QUMU</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/ACIA' title='Acacia Communications'>ACIA</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/DRWI' title='DragonWave Inc.'>DRWI</a> <font color='red'>-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3210845\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3:00 pm\" data-tweet=\"$ACTA $MTLS $EVBG - Technology - Top 5 Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3210845-technology-top-5-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3210845-technology-top-5-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210842\" data-ts=\"1474916064\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210842-deutsche-plunge-helps-send-money-flowing-government-paper\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche plunge helps send money flowing into government paper</a></h4><ul>\n<li>A weekend German media report <a href=\"https://seekingalpha.com/news/3210678-deutsche-bank-slumps-capital-concerns\" target=\"_blank\">said the government </a>has no intention of coming to the rescue of Deutsche Bank, sending that stock <font color=\"red\">lower by more than 7%</font> and the Dax <font color=\"red\">by 2.2%</font>. Of course, governments always say this ... usually not long before announcing a support package.</li>\n<li>The U.S. major averages are <font color=\"red\">lower by about 0.85%</font>, and there's the added uncertainty of tonight's first presidential debate.</li>\n<li>The 10-year U.S. Treasury yield is down by three basis points to 1.585% - roughly the lowest level this month - and traders <a href=\"http://www.cmegroup.com/trading/interest-rates/stir/30-day-federal-fund.html\" target=\"_blank\">are cutting bets</a> on the odds of a December rate hike even as the Fed more or less last week promised us one.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/TLT\" title=\"iShares 20+ Year Treasury Bond ETF\">TLT</a> <font color=\"green\">+0.4%</font>, <a href=\"https://seekingalpha.com/symbol/TBT\" title=\"ProShares UltraShort 20+ Year Treasury ETF\">TBT</a> <font color=\"red\">-0.8%</font>\n</li>\n<li>Across the pond, the German 10-year Bund yield is down 3.3 basis points to <strong>negative 0.113%</strong> (perhaps the easiest \"rescue\" for DB would be positive rates).</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/TBT\" title=\"ProShares UltraShort 20+ Year Treasury ETF\">TBT</a>, <a href=\"https://seekingalpha.com/symbol/TLT\" title=\"iShares 20+ Year Treasury Bond ETF\">TLT</a>, <a href=\"https://seekingalpha.com/symbol/TMV\" title=\"Direxion Daily 20+ Year Treasury Bear 3x Shares ETF\">TMV</a>, <a href=\"https://seekingalpha.com/symbol/TBF\" title=\"ProShares Short 20+ Year Treasury ETF\">TBF</a>, <a href=\"https://seekingalpha.com/symbol/EDV\" title=\"Vanguard Extended Duration Treasury ETF\">EDV</a>, <a href=\"https://seekingalpha.com/symbol/TMF\" title=\"Direxion Daily 30-Year Treasury Bull 3x Shares ETF\">TMF</a>, <a href=\"https://seekingalpha.com/symbol/TTT\" title=\"ProShares UltraPro Short 20+ Year Treasury ETF\">TTT</a>, <a href=\"https://seekingalpha.com/symbol/ZROZ\" title=\"PIMCO 25+ Year Zero Coupon U.S. Treasury Index ETF\">ZROZ</a>, <a href=\"https://seekingalpha.com/symbol/VGLT\" title=\"Vanguard Long-Term Government Bond Index ETF\">VGLT</a>, <a href=\"https://seekingalpha.com/symbol/TLH\" title=\"iShares 10-20 Year Treasury Bond ETF\">TLH</a>, <a href=\"https://seekingalpha.com/symbol/SBND\" title=\"DB 3x Short 25+ Year Treasury Bond ETN\">SBND</a>, <a href=\"https://seekingalpha.com/symbol/UBT\" title=\"ProShares Ultra 20+ Year Treasury ETF\">UBT</a>, <a href=\"https://seekingalpha.com/symbol/DLBS\" title=\"iPath U.S. Treasury Long Bond Bear ETN\">DLBS</a>, <a href=\"https://seekingalpha.com/symbol/TLO\" title=\"SPDR Barclays Long Term Treasury ETF\">TLO</a>, <a href=\"https://seekingalpha.com/symbol/BUNL\" title=\"DB German Bund Futures ETN\">BUNL</a>, <a href=\"https://seekingalpha.com/symbol/BUNT\" title=\"PowerShares 3x German Bund Futures ETN\">BUNT</a>, <a href=\"https://seekingalpha.com/symbol/LBND\" title=\"DB 3x Long 25+ Year Treasury Bond ETN\">LBND</a>, <a href=\"https://seekingalpha.com/symbol/GGOV\" title=\"ProShares German Sovereign/Sub-Sovereign ETF\">GGOV</a>, <a href=\"https://seekingalpha.com/symbol/VUSTX\" title=\"Vanguard Long Term Treasury Fund Inv\">VUSTX</a>, <a href=\"https://seekingalpha.com/symbol/DLBL\" title=\"iPath U.S. Treasury Long Bond Bull ETN\">DLBL</a>, <a href=\"https://seekingalpha.com/symbol/TYBS\" title=\"Direxion Daily 20+ Year Treasury Bear 1x Shares ETF\">TYBS</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210842\" data-linked=\"Deutsche plunge helps send money flowing into government paper\" data-tweet=\"$TLT $TBT $TMV - Deutsche plunge helps send money flowing into government paper https://seekingalpha.com/news/3210842-deutsche-plunge-helps-send-money-flowing-government-paper?source=tweet\" data-url=\"https://seekingalpha.com/news/3210842-deutsche-plunge-helps-send-money-flowing-government-paper\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210829\" data-ts=\"1474913399\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210829-energy-materials-top-5-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm</a></h4><ul> <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CHMT' title='Chemtura Corporation'>CHMT</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/HK' title='Halcon Resources Corporation'>HK</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/TAT' title='TransAtlantic Petroleum Ltd.'>TAT</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/CPPL' title='Columbia Pipeline Partners LP'>CPPL</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/CNX' title='CNX Resources Corporation'>CNX</a> <font color='green'>+6%</font>.</li> <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/GLF' title='GulfMark Offshore, Inc.'>GLF</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/TANH' title='Tantech Holdings'>TANH</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/FELP' title='Foresight Energy LP'>FELP</a> <font color='red'>-5%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3210829\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm\" data-tweet=\"$CHMT $HKRS $TAT - Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3210829-energy-materials-top-5-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3210829-energy-materials-top-5-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210823\" data-ts=\"1474912387\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HIMX\" target=\"_blank\">HIMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210823-himax-technologiesminus-18-downgraded-to-hold-nomura-securities\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Himax Technologies -18%; downgraded to Hold at Nomura Securities</a></h4><ul>\n<li>Analyst Donnie Teng <a href=\"http://blogs.barrons.com/techtraderdaily/2016/09/26/himax-nomura-cuts-to-hold-on-long-wait-for-microsofts-hololens/\" target=\"_blank\">projects</a> weaker AR device shipments, specifically for Microsoft's HoloLens, for which he doesn't see meaningful sales volume until at least H2 2017.</li>\n<li>Lowers Himax Technologies' (<a href=\"https://seekingalpha.com/symbol/HIMX\" title=\"Himax Technologies, Inc.\">HIMX</a> <font color=\"red\">-18.5%</font>) price target from $12 to $10.20 (current price $8.78), 2016 revenue estimate from $809M to $801M and EPS estimate from $0.37 to $0.35. Decreases 2017 revenue estimate from $925M to $904M and EPS estimate from $0.45 to $0.41.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210823\" data-linked=\"Himax Technologies -18%; downgraded to Hold at Nomura Securities\" data-tweet=\"$HIMX - Himax Technologies -18%; downgraded to Hold at Nomura Securities https://seekingalpha.com/news/3210823-himax-technologiesminus-18-downgraded-to-hold-nomura-securities?source=tweet\" data-url=\"https://seekingalpha.com/news/3210823-himax-technologiesminus-18-downgraded-to-hold-nomura-securities\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>87&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210819\" data-ts=\"1474911670\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VEON\" target=\"_blank\">VEON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210819-fridman-vimpelcom-fitter-company-telenor-sells-out\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fridman: VimpelCom fitter company as Telenor sells out</a></h4><ul>   <li>VimpelCom (VIP) is <a href=\"http://www.bloomberg.com/news/articles/2016-09-26/billionaire-fridman-says-telenor-exit-makes-vimpelcom-healthier\" target=\"_blank\">in a better position</a> now that Norwegian telecom Telenor (<a href=\"https://seekingalpha.com/symbol/TELNY\" title=\"Telenor ASA ADR\">OTCPK:TELNY</a> <font color=\"red\">-2%</font>) has begun selling off its piece of the company, says Russian billionaire (and VimpelCom co-owner) Mikhail Fridman.</li>    <li>After pursuing a way to get out from its stake for months, Telenor <a href=\"https://seekingalpha.com/news/3208165-vimpelcom-slides-6_3-percent-telenor-puts-555m-worth-sale\" target=\"_blank\">started selling its stake</a> (then 33% of VimpelCom) a couple of weeks ago.</li>    <li>Telenor's ownership created an \"abnormal\" situation in some markets, Fridman says, with board meetings where \"half of the members would usually leave the room because they had a conflict of interest.\"</li>    <li>VimpelCom isn't looking at geographic expansion now, he says, but rather focusing on changing its business model from a low-margin infrastructure play to offering integrated services with content providers, including Uber Technologies.</li>    <li>VimpelCom shares are <font color=\"red\">off 9%</font> since Telenor's sale began earlier this month.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3210819\" data-linked=\"Fridman: VimpelCom fitter company as Telenor sells out\" data-tweet=\"$VEON $VEON $TELNY - Fridman: VimpelCom fitter company as Telenor sells out https://seekingalpha.com/news/3210819-fridman-vimpelcom-fitter-company-telenor-sells-out?source=tweet\" data-url=\"https://seekingalpha.com/news/3210819-fridman-vimpelcom-fitter-company-telenor-sells-out\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210815\" data-ts=\"1474910170\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NLS\" target=\"_blank\">NLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210815-nautilus-falls-back-after-b-riley-dowgnrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nautilus falls back after B. Riley dowgnrade</a></h4><ul> <li>Nautilus (<a href='https://seekingalpha.com/symbol/NLS' title='Nautilus, Inc.'>NLS</a> <font color='red'>-5.6%</font>) is down sharply after B. Riley <a href=\"http://www.streetinsider.com/Downgrades/B.+Riley+Downgrades+Nautilus+%28NLS%29+to+Neutral/12069214.html\" target=\"_blank\">downgrades</a> the stock to a Neutral rating in a cut tied to valuation.</li> <li>Shares of Nautilus are up 39% YTD in a run that has stretched earnings multiples beyond historic norms.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3210815\" data-linked=\"Nautilus falls back after B. Riley dowgnrade\" data-tweet=\"$NLS - Nautilus falls back after B. Riley dowgnrade https://seekingalpha.com/news/3210815-nautilus-falls-back-after-b-riley-dowgnrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3210815-nautilus-falls-back-after-b-riley-dowgnrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210814\" data-ts=\"1474909898\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRM\" target=\"_blank\">CRM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210814-morgan-stanley-considers-salesforce-twitter-deal-probability-low\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley considers Salesforce, Twitter deal probability low</a></h4><ul>\n<li>Citi's Walter Pritchard <a href=\"https://seekingalpha.com/news/3210596-citi-considers-twitter-salesforce-deal-unlikely\" target=\"_blank\">expressed like sentiment</a> regarding a hypothetical <a href=\"https://seekingalpha.com/news/3210545-twitter-plus-17-percent-pre-market-m-speculation-recirculating\" target=\"_blank\">Salesforce buyout of Twitter</a> last Friday.</li>\n<li>Morgan Stanley's Keith Weiss today <a href=\"http://blogs.barrons.com/techtraderdaily/2016/09/26/salesforce-low-probability-theyd-buy-twitter-says-morgan-stanley/\" target=\"_blank\">cites</a> \"an inability to see revenue synergies from the combination.\"</li>\n<li>Further: \"Frankly, we struggle to see any near-term revenue opportunities from the combination of Salesforce.com and Twitter that aren\u2019t available today via the current partnership \u2013 i.e . social listening/social media management. Vala\u2019s list, while interesting potential opportunities for Twitter, seem to have limited adjacency to the current Salesforce.com solutions portfolio or core customer base. Even the longer-term value add of some insights yielded from Twitter data via Salesforce.com\u2019s developing AI capabilities is difficult for us to see. Predictive marketing capabilities in the Marketing Cloud? Insight into how to better sell to Twitter users?\"</li>\n<li>Weiss assumes a $14B-$17B theoretical acquisition range should Salesforce (<a href=\"https://seekingalpha.com/symbol/CRM\" title=\"Salesforce.com, Inc.\">CRM</a> <font color=\"red\">-0.7%</font>) pursue Twitter (<a href=\"https://seekingalpha.com/symbol/TWTR\" title=\"Twitter, Inc.\">TWTR</a> <font color=\"red\">-3.1%</font>) (based on 5x-7x average forward EV/sales of similar Salesforce transactions).</li>\n<li>Retains Salesforce at Overweight with a $107 price target (current price $69.94).</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210814\" data-linked=\"Morgan Stanley considers Salesforce, Twitter deal probability low\" data-tweet=\"$CRM $CRM $TWTR - Morgan Stanley considers Salesforce, Twitter deal probability low https://seekingalpha.com/news/3210814-morgan-stanley-considers-salesforce-twitter-deal-probability-low?source=tweet\" data-url=\"https://seekingalpha.com/news/3210814-morgan-stanley-considers-salesforce-twitter-deal-probability-low\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210809\" data-ts=\"1474909324\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210809-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/FNBC' title='First NBC Bank Holding Company'>OTC:FNBC</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/AIII' title='ACRE Realty Investors Inc.'>AIII</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/AAMC' title='Altisource Asset Management Corp'>AAMC</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/DB' title='Deutsche Bank AG'>DB</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/HGSH' title='China HGS Real Estate, Inc.'>HGSH</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3210809\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$FNBC $AIII $AAMC - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3210809-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3210809-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210805\" data-ts=\"1474908522\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210805-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ARRY' title='Array BioPharma Inc.'>ARRY</a> <font color='green'>+64%</font>. <a href='https://seekingalpha.com/symbol/SMMT' title='Summit Therapeutics'>SMMT</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/RGSE' title='RGS Energy, Inc.'>RGSE</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/ACTA' title='Actua Corporation'>ACTA</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/CHMT' title='Chemtura Corporation'>CHMT</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/GWPH' title='GW Pharmaceuticals plc'>GWPH</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/LPCN' title='Lipocine Inc.'>LPCN</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/ZYNE' title='Zynerba Pharmaceuticals'>ZYNE</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/VVUS' title='Vivus, Inc.'>VVUS</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/CHMA' title='Chiasma'>CHMA</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/PTIE' title='Pain Therapeutics'>PTIE</a> <font color='red'>-54%</font>. <a href='https://seekingalpha.com/symbol/DRRX' title='Durect Corporation'>DRRX</a> <font color='red'>-32%</font>. <a href='https://seekingalpha.com/symbol/SALE' title='RetailMeNot, Inc.'>SALE</a> <font color='red'>-21%</font>. SPU <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/UTI' title='Universal Technical Institute'>UTI</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/HIMX' title='Himax Technologies, Inc.'>HIMX</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/ACOR' title='Acorda Therapeutics, Inc.'>ACOR</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/LE' title='Lands&#39; End, Inc.'>LE</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/GBSN-OLD' title='Great Basin Scientific, Inc.'>GBSN</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/MHGC' title='Morgans Hotel Group Co.'>MHGC</a> <font color='red'>-11%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3210805\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$ARRY $SMMT $RGSE - Midday Gainers / Losers https://seekingalpha.com/news/3210805-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3210805-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210703\" data-ts=\"1474907388\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTIE\" target=\"_blank\">PTIE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210703-fda-rejects-pain-therapeutics-remoxy-er-marketing-application-shares-plummet-67-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA rejects Pain Therapeutics&#39; Remoxy ER marketing application; shares plummet 67% premarket</a></h4><ul>\n<li>Thinly traded micro cap Pain Therapeutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/PTIE\" title=\"Pain Therapeutics\">PTIE</a>) craters <font color=\"red\">67%</font> premarket on increased volume in response to its announcement that it received a Complete Response Letter (CRL) from the FDA regarding its New Drug Application (NDA) seeking approval of abuse-deterrent <a href=\"http://www.durect.com/products/development/remoxy/\" target=\"_blank\">REMOXY ER</a> (oxycodone capsules CII).</li>\n<li>The CRL informs the company that additional actions and data are required for approval. Management says the actions will take about a year to complete and could cost $5M.</li>\n<li>Specifically,  to support a claim against abuse by injection, it will need to repeat an injectability/syringeability study using thin films of drug, smaller volumes of solvents, additional mixed solvents and alternative extraction methods and syringe filter. To support a claim against abuse by inhalation, it will need to repeat a volatilization study using the same thickness for each drug to increase surface area. To support a claim against abuse by snorting, it will need to conduct an intranasal abuse potential study in human volunteers (the company submitted animal data in its NDA) with drug applied directly inside the human nasal cavity.</li>\n<li>In addition, the agency stated that Pain's clinical data to support a claim against abuse by chewing is not sufficient and it will need to submit a revised proposed label to indicate that the results from the study do not support the claim.</li>\n<li>The filing was the company's third attempt at approval.</li>\n<li>The company will host a conference call this morning at 9:00 am ET to discuss the situation.</li>\n<li>Remoxy licensor DURECT (<a href=\"https://seekingalpha.com/symbol/DRRX\" title=\"Durect Corporation\">DRRX</a> <font color=\"red\">-31.8%</font>) is feeling a bit of pain as well.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210703\" data-linked=\"FDA rejects Pain Therapeutics&#39; Remoxy ER marketing application; shares plummet 67% premarket\" data-tweet=\"$PTIE $SAVA $DRRX - FDA rejects Pain Therapeutics&#39; Remoxy ER marketing application; shares plummet 67% premarket https://seekingalpha.com/news/3210703-fda-rejects-pain-therapeutics-remoxy-er-marketing-application-shares-plummet-67-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3210703-fda-rejects-pain-therapeutics-remoxy-er-marketing-application-shares-plummet-67-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210796\" data-ts=\"1474905682\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210796-consumer-goods-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer Goods - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/NTZ' title='Natuzzi S.p.A.'>NTZ</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> SPU <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/FORD' title='Forward Industries, Inc.'>FORD</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/NLS' title='Nautilus, Inc.'>NLS</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/BREW' title='Craft Brew Alliance Inc'>BREW</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3210796\" data-linked=\"Consumer Goods - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$NTZ $FTFT $FORD - Consumer Goods - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3210796-consumer-goods-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3210796-consumer-goods-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210792\" data-ts=\"1474904234\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RF\" target=\"_blank\">RF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210792-rough-session-for-financials-deutsche-bank-and-interest-rates-slide\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rough session for financials as Deutsche Bank and interest rates slide</a></h4><ul>\n<li>The S&amp;P 500 is<font color=\"red\"> lower by 0.65%</font>, but the <a href=\"https://seekingalpha.com/symbol/XLF\" title=\"Financial Select Sector SPDR ETF\">XLF</a> is down <font color=\"red\">nearly double </font>that amount, with Deutsche Bank<font color=\"red\"> lower by 7%</font> on <a href=\"https://seekingalpha.com/news/3210731-deutsche-bank-tumble-leads-europe-lower\" target=\"_blank\">capital worries</a> and interest rates sliding to a three-week low.</li>\n<li>At 1.59% on the 10-year Treasury, the yield curve in the space of a few sessions has erased all of its post-Labor Day steepening, and yield-starved players are in retreat.</li>\n<li>Regions Financial (<a href=\"https://seekingalpha.com/symbol/RF\" title=\"Regions Financial Corporation\">RF</a> <font color=\"red\">-1.9%</font>), KeyCorp (<a href=\"https://seekingalpha.com/symbol/KEY\" title=\"KeyCorp\">KEY</a> <font color=\"red\">-1.7%</font>), SunTrust (<a href=\"https://seekingalpha.com/symbol/STI\" title=\"SunTrust Banks, Inc.\">STI</a> <font color=\"red\">-1.9%</font>), Fifth Third (<a href=\"https://seekingalpha.com/symbol/FITB\" title=\"Fifth Third Bancorp\">FITB</a> <font color=\"red\">-1.6%</font>), MetLife (<a href=\"https://seekingalpha.com/symbol/MET\" title=\"MetLife, Inc.\">MET</a> <font color=\"red\">-1.6%</font>), Lincoln National (<a href=\"https://seekingalpha.com/symbol/LNC\" title=\"Lincoln National Corporation\">LNC</a> <font color=\"red\">-1.3%</font>).</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/XLF\" title=\"Financial Select Sector SPDR ETF\">XLF</a>, <a href=\"https://seekingalpha.com/symbol/FAS\" title=\"Direxion Daily Financial Bull 3x Shares ETF\">FAS</a>, <a href=\"https://seekingalpha.com/symbol/FAZ\" title=\"Direxion Daily Financial Bear 3x Shares ETF\">FAZ</a>, <a href=\"https://seekingalpha.com/symbol/UYG\" title=\"ProShares Ultra Financials ETF\">UYG</a>, <a href=\"https://seekingalpha.com/symbol/VFH\" title=\"Vanguard Financials ETF\">VFH</a>, <a href=\"https://seekingalpha.com/symbol/IYF\" title=\"iShares U.S. Financials ETF\">IYF</a>, <a href=\"https://seekingalpha.com/symbol/BTO\" title=\"John Hancock Financial Opportunity Fund\">BTO</a>, <a href=\"https://seekingalpha.com/symbol/IYG\" title=\"iShares U.S. Financial Services ETF\">IYG</a>, <a href=\"https://seekingalpha.com/symbol/FNCL\" title=\"Fidelity MSCI Financials Index ETF\">FNCL</a>, <a href=\"https://seekingalpha.com/symbol/SEF\" title=\"ProShares Short Financials ETF\">SEF</a>, <a href=\"https://seekingalpha.com/symbol/FXO\" title=\"First Trust Financials AlphaDEX ETF\">FXO</a>, <a href=\"https://seekingalpha.com/symbol/RYF\" title=\"Invesco S&amp;P Equal Weight Financial ETF\">RYF</a>, <a href=\"https://seekingalpha.com/symbol/FINU\" title=\"ProShares UltraPro Financials ETF\">FINU</a>, <a href=\"https://seekingalpha.com/symbol/RWW\" title=\"Oppenheimer Financials Sector Revenue ETF\">RWW</a>, <a href=\"https://seekingalpha.com/symbol/XLFS\" title=\"Financial Services Select Sector SPDR ETF\">XLFS</a>, <a href=\"https://seekingalpha.com/symbol/FINZ\" title=\"ProShares UltraPro Short Financials ETF\">FINZ</a>, <a href=\"https://seekingalpha.com/symbol/JHMF\" title=\"John Hancock Multifactor Financials ETF\">JHMF</a>, <a href=\"https://seekingalpha.com/symbol/FAZZ\" title=\"Direxion Daily Financial Bear 1x Shares ETF\">FAZZ</a>, <a href=\"https://seekingalpha.com/symbol/FNCF\" title=\"iShares Edge MSCI Multifactor Financials ETF\">FNCF</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210792\" data-linked=\"Rough session for financials as Deutsche Bank and interest rates slide\" data-tweet=\"$RF $XLF $RF - Rough session for financials as Deutsche Bank and interest rates slide https://seekingalpha.com/news/3210792-rough-session-for-financials-deutsche-bank-and-interest-rates-slide?source=tweet\" data-url=\"https://seekingalpha.com/news/3210792-rough-session-for-financials-deutsche-bank-and-interest-rates-slide\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210790\" data-ts=\"1474903847\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CZR\" target=\"_blank\">CZR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210790-caesars-slips-double-digit-territory-after-refinancing-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Caesars slips into double-digit territory after refinancing update</a></h4><ul> <li>Shares of Caesars Entertainment (<a href=\"https://seekingalpha.com/symbol/CZR\" title=\"Caesars Entertainment\">CZR</a> <font color=\"green\">+0.1%</font>) briefly crossed over $10. The casino stock hasn't seen a closing price in the double digits since early last year.</li> <li>The company issued a statement today on the \"significant\" progress of its debt restructuring and the refinancing of its operating unit.</li> <li>Caesars update: \"Although there can be no assurance, Caesars Entertainment and CEOC remain optimistic that an agreement will be reached to permit Caesars Entertainment to continue to support CEOC's plan in conjunction with consensus among CEOC's major creditor constituencies.\"</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3210790\" data-linked=\"Caesars slips into double-digit territory after refinancing update\" data-tweet=\"$CZR - Caesars slips into double-digit territory after refinancing update https://seekingalpha.com/news/3210790-caesars-slips-double-digit-territory-after-refinancing-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3210790-caesars-slips-double-digit-territory-after-refinancing-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:30 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210771\" data-ts=\"1474902048\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210771-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ARRY' title='Array BioPharma Inc.'>ARRY</a> <font color='green'>+55%</font>. <a href='https://seekingalpha.com/symbol/LPCN' title='Lipocine Inc.'>LPCN</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/SMMT' title='Summit Therapeutics'>SMMT</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/GWPH' title='GW Pharmaceuticals plc'>GWPH</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/VRAY' title='ViewRay'>VRAY</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/PTIE' title='Pain Therapeutics'>PTIE</a> <font color='red'>-54%</font>. <a href='https://seekingalpha.com/symbol/DRRX' title='Durect Corporation'>DRRX</a> <font color='red'>-30%</font>. <a href='https://seekingalpha.com/symbol/ACOR' title='Acorda Therapeutics, Inc.'>ACOR</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/GBSN-OLD' title='Great Basin Scientific, Inc.'>GBSN</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/BABY' title='Natus Medical Incorporated'>BABY</a> <font color='red'>-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3210771\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$ARRY $LPCN $SMMT - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3210771-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3210771-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210778\" data-ts=\"1474901933\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OSK\" target=\"_blank\">OSK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210778-oshkosh-upgraded-credit-suisse-following-friday-selloff\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oshkosh upgraded at Credit Suisse following Friday selloff</a></h4><ul>     <li>Oshkosh (<a href=\"https://seekingalpha.com/symbol/OSK\" title=\"Oshkosh Corporation\">OSK</a> <font color=\"green\">+2.9%</font>) is <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/16/09/8493919/oshkosh-gets-credit-suisse-upgrade-following-selloff\" target=\"_blank\">upgraded</a> to Neutral from Underperform with a $54 price target, raised from $50, at Credit Suisse, which believes Friday's selloff was overdone in reaction to disappointing but realistic FY 2017 guidance.</li>     <li>OSK shares fell 10.6% on Friday after raising its FY 2016 EPS guidance on revenues of $6.1B-$6.2B to $2.85-$3.00 from a previous outlook of $2.60-$2.80 on revenues of $6B-$6.1B, but offering a FY 2017 EPS outlook of $3.00-$3.40, which came in below analyst consensus guidance of $3.61.</li>     <li>The firm believes OSK\u2019s defense business has been underappreciated, and says the company has won additional international M-ATV business, along with the JLTV, which is expected to support EPS if the Access equipment segment suffers a downturn.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3210778\" data-linked=\"Oshkosh upgraded at Credit Suisse following Friday selloff\" data-tweet=\"$OSK - Oshkosh upgraded at Credit Suisse following Friday selloff https://seekingalpha.com/news/3210778-oshkosh-upgraded-credit-suisse-following-friday-selloff?source=tweet\" data-url=\"https://seekingalpha.com/news/3210778-oshkosh-upgraded-credit-suisse-following-friday-selloff\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210776\" data-ts=\"1474900763\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LE\" target=\"_blank\">LE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210776-lands-end-dives-after-ceo-exit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lands&#39; End dives after CEO exit</a></h4><ul> <li>Investors are scrambling out of Lands' End (NASDAQ:<a href=\"https://seekingalpha.com/symbol/LE\" title=\"Lands' End, Inc.\">LE</a>) after the company's high-profile CEO stepped down.</li> <li>Federica Marchionni was attempting to add more fashionable lines at the company and delve into athletic apparel, meaning the CEO switch could reset strategy again.</li> <li>Shares are <font color=\"red\">down 11.64%</font> to $15.90 vs. a 52-week trading range of $14.03 to $28.08.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3210696-lands-end-ceo-steps\" target=\"_blank\">Lands' End CEO steps down</a> (Sept. 26)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3210776\" data-linked=\"Lands&#39; End dives after CEO exit\" data-tweet=\"$LE - Lands&#39; End dives after CEO exit https://seekingalpha.com/news/3210776-lands-end-dives-after-ceo-exit?source=tweet\" data-url=\"https://seekingalpha.com/news/3210776-lands-end-dives-after-ceo-exit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210760\" data-ts=\"1474898294\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBH\" target=\"_blank\">SBH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210760-sally-beauty-holdings-rallies-after-s-and-p-midcap-400-invite\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sally Beauty Holdings rallies after S&amp;P MidCap 400 invite</a></h4><ul> <li>Shares of Sally Beauty Holdings (<a href='https://seekingalpha.com/symbol/SBH' title='Sally Beauty Holdings, Inc.'>SBH</a> <font color='green'>+5.2%</font>) rally after the company is added to the S&amp;P MidCap 400 Index.</li><li>Sally Beauty officially joins the index after the market closes on Tuesday.</li> <li><a href=\"http://www.spice-indices.com/idpfiles/spice-assets/resources/public/documents/407773_spin3honapdrrd26.pdf\" target=\"_blank\">S&amp;P Dow Jones Indices update</a> (.pdf)</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3210760\" data-linked=\"Sally Beauty Holdings rallies after S&amp;P MidCap 400 invite\" data-tweet=\"$SBH - Sally Beauty Holdings rallies after S&amp;P MidCap 400 invite https://seekingalpha.com/news/3210760-sally-beauty-holdings-rallies-after-s-and-p-midcap-400-invite?source=tweet\" data-url=\"https://seekingalpha.com/news/3210760-sally-beauty-holdings-rallies-after-s-and-p-midcap-400-invite\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210757\" data-ts=\"1474897929\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SQM\" target=\"_blank\">SQM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210757-china-s-tianqi-lithium-to-invest-200m-in-chile-s-sqm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China\u2019s Tianqi Lithium to invest more than $200M in Chile\u2019s SQM</a></h4><ul>     <li>Sociedad Quimica y Minera (<a href=\"https://seekingalpha.com/symbol/SQM\" title=\"Chemical &amp; Mining Co. of Chile Inc.\">SQM</a> <font color=\"green\">+5.3%</font>) pops higher at the open as China's Tianqi Lithium says it <a href=\"https://www.ft.com/content/8ad922b1-0f37-372c-af88-7bf604ee3cac\" target=\"_blank\">plans to invest ~$209M</a> for a 2.6% stake for the Chilean company, in a deal that could pave the way for a larger stake in one of the world\u2019s largest producers of the battery material.</li>     <li>Tianqi says it will buy shares for $38 each from SailtingStone Capital Partners, which currently holds 20% of SQM's NYSE-listed shares.</li>     <li>Tianqi reportedly already has <a href=\"https://seekingalpha.com/news/3207939-china-s-top-lithium-producer-proposes-deal-stake-chiles-sqm\" target=\"_blank\">signed a non-binding offer</a> to bid for a 23% stake in SQM.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3210757\" data-linked=\"China\u2019s Tianqi Lithium to invest more than $200M in Chile\u2019s SQM\" data-tweet=\"$SQM - China\u2019s Tianqi Lithium to invest more than $200M in Chile\u2019s SQM https://seekingalpha.com/news/3210757-china-s-tianqi-lithium-to-invest-200m-in-chile-s-sqm?source=tweet\" data-url=\"https://seekingalpha.com/news/3210757-china-s-tianqi-lithium-to-invest-200m-in-chile-s-sqm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210755\" data-ts=\"1474897423\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHO\" target=\"_blank\">SHO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210755-morgan-stanley-cuts-view-of-lodging-names\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley cuts view of lodging names</a></h4><ul><li>Alongside <a href=\"https://seekingalpha.com/news/3210697-sunstone-hotel-downgraded-morgan-stanley\" target=\"_blank\">an earlier reported</a> downgrade of Sunstone Hotel Investors (<a href='https://seekingalpha.com/symbol/SHO' title='Sunstone Hotel Investors, Inc.'>SHO</a> <font color='red'>-2.9%</font>), Morgan Stanley downgrades DiamondRock Hospitality (<a href='https://seekingalpha.com/symbol/DRH' title='DiamondRock Hospitality Company'>DRH</a> <font color='red'>-2.3%</font>), Hyatt Hotels (<a href='https://seekingalpha.com/symbol/H' title='Hyatt Hotels Corporation'>H</a> <font color='red'>-3%</font>), and InterContinental Hotels (<a href='https://seekingalpha.com/symbol/IHG' title='InterContinental Hotels Group PLC'>IHG</a> <font color='red'>-4.4%</font>) to Underweight from Equal Weight.</li><li>Behind the downgrades, Morgan analyst Thomas Allen cut his forecast for U.S. RevPAR growth next year to 1% from 2.4%, and for 2018 to -1% from 1.5%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3210755\" data-linked=\"Morgan Stanley cuts view of lodging names\" data-tweet=\"$SHO $SHO $DRH - Morgan Stanley cuts view of lodging names https://seekingalpha.com/news/3210755-morgan-stanley-cuts-view-of-lodging-names?source=tweet\" data-url=\"https://seekingalpha.com/news/3210755-morgan-stanley-cuts-view-of-lodging-names\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210754\" data-ts=\"1474897109\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBY\" target=\"_blank\">SBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210754-jpmorgan-rings-register-on-silver-bay-realty\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JPMorgan rings the register on Silver Bay Realty</a></h4><ul>\n<li>With Silver Bay (NYSE:<a href=\"https://seekingalpha.com/symbol/SBY\" title=\"Silver Bay Realty Trust Corp.\">SBY</a>) <font color=\"green\">up about 50%</font> from the February market low, JPMorgan recommends taking some profits with a downgrade to Neutral from Overweight.</li>\n<li>Shares are <font color=\"red\">lower by 2.3%</font> in early action.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210754\" data-linked=\"JPMorgan rings the register on Silver Bay Realty\" data-tweet=\"$SBY - JPMorgan rings the register on Silver Bay Realty https://seekingalpha.com/news/3210754-jpmorgan-rings-register-on-silver-bay-realty?source=tweet\" data-url=\"https://seekingalpha.com/news/3210754-jpmorgan-rings-register-on-silver-bay-realty\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210743\" data-ts=\"1474896316\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARRY\" target=\"_blank\">ARRY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210743-array-bios-encorafenib-binimetinib-combo-successful-in-late-stage-melanoma-study-shares-up-29\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Array Bio&#39;s encorafenib-binimetinib combo successful in late-stage melanoma study; shares up 29% premarket</a></h4><ul>\n<li>Micro cap Array BioPharma (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ARRY\" title=\"Array BioPharma Inc.\">ARRY</a>) perks up <font color=\"green\">29%</font> premarket on robust volume in response to its announcement of positive results in a Phase 3 clinical trial, COLUMBUS, assessing the combination of LGX818 (encorafenib) and MEK162 (binimetinib) for the treatment of patients with BRAF-positive, advanced, unresectable or metastatic melanoma.</li>\n<li>The study met its primary endpoint of a statistically significant improvement in progression-free survival (PFS) compared to vemurafenib [Roche's (<a href=\"https://seekingalpha.com/symbol/RHHBY\" title=\"Roche Holding Ltd ADR\">OTCQX:RHHBY</a>) <a href=\"http://www.gene.com/download/pdf/zelboraf_prescribing.pdf\" target=\"_blank\">Zelboraf</a>] alone. Specifically, median PFS for the combination was 14.9 months versus 7.3 months for vemurafenib (p&lt;0.001).</li>\n<li>Encorafenib is a BRAF inhibitor acquired from Novartis (NYSE:<a href=\"https://seekingalpha.com/symbol/NVS\" title=\"Novartis AG\">NVS</a>) in early 2015. <a href=\"http://www.arraybiopharma.com/product-pipeline/binimetinib/\" target=\"_blank\">Binimetinib </a>is a small molecule MEK inhibitor.</li>\n<li>The company intends to file marketing applications as soon as feasible.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210743\" data-linked=\"Array Bio&#39;s encorafenib-binimetinib combo successful in late-stage melanoma study; shares up 29% premarket\" data-tweet=\"$ARRY $ARRY $RHHBY - Array Bio&#39;s encorafenib-binimetinib combo successful in late-stage melanoma study; shares up 29% premarket https://seekingalpha.com/news/3210743-array-bios-encorafenib-binimetinib-combo-successful-in-late-stage-melanoma-study-shares-up-29?source=tweet\" data-url=\"https://seekingalpha.com/news/3210743-array-bios-encorafenib-binimetinib-combo-successful-in-late-stage-melanoma-study-shares-up-29\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210736\" data-ts=\"1474895825\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACIA\" target=\"_blank\">ACIA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210736-acacia-communications-files-for-up-to-450m-common-stock-offering-provides-q3-guidanceminus-7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acacia Communications files for up to $450M common stock offering, provides Q3 guidance; -7% pre-market</a></h4><ul>\n<li>Acacia Communications (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ACIA\" title=\"Acacia Communications\">ACIA</a>) <a href=\"https://www.sec.gov/Archives/edgar/data/1651235/000119312516719131/d243388ds1.htm\" target=\"_blank\">proposes</a> to offer $125M with the remainder to be offered by selling shareholders. Proceeds of the latter will not go to the company.</li>\n<li>For Q3, revenue of $127M-$131M, net income of $29M-$33M and EPS of $0.72-$0.81 are <a href=\"https://www.sec.gov/Archives/edgar/data/1651235/000119312516719139/d264830d8k.htm\" target=\"_blank\">expected</a> (compare to <a href=\"https://seekingalpha.com/news/3203073-acacia-communications-plus-30-percent-posting-101-percent-revenue-growth\" target=\"_blank\">Q2 results</a>).</li>\n<li>On Friday, the company closed <font color=\"green\">285% above</font> its first-day-of-trading open price (in May), though is off this morning on news of the intended offering.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210736\" data-linked=\"Acacia Communications files for up to $450M common stock offering, provides Q3 guidance; -7% pre-market\" data-tweet=\"$ACIA - Acacia Communications files for up to $450M common stock offering, provides Q3 guidance; -7% pre-market https://seekingalpha.com/news/3210736-acacia-communications-files-for-up-to-450m-common-stock-offering-provides-q3-guidanceminus-7?source=tweet\" data-url=\"https://seekingalpha.com/news/3210736-acacia-communications-files-for-up-to-450m-common-stock-offering-provides-q3-guidanceminus-7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210740\" data-ts=\"1474895781\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QSR\" target=\"_blank\">QSR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210740-longbow-turns-negative-on-restaurant-brands-international\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Longbow turns negative on Restaurant Brands International</a></h4><ul> <li>Shares of Restaurant Brands International (NYSE:<a href=\"https://seekingalpha.com/symbol/QSR\" title=\"Restaurant Brands International Inc.\">QSR</a>) are on watch after Longbow Research<a href=\"http://www.streetinsider.com/Downgrades/Longbow+Research+Downgrades+Restaurant+Brands+International+%28QSR%29+to+Underperform/12069226.html\" target=\"_blank\"> downgrades</a> the restaurant stock to an Underperform rating from Neutral.</li> <li>The investment firm's price target of $35 implies a steep downturn.</li> <li>QSR <font color=\"red\">-2.43%</font> premarket to $44.98.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3210740\" data-linked=\"Longbow turns negative on Restaurant Brands International\" data-tweet=\"$QSR - Longbow turns negative on Restaurant Brands International https://seekingalpha.com/news/3210740-longbow-turns-negative-on-restaurant-brands-international?source=tweet\" data-url=\"https://seekingalpha.com/news/3210740-longbow-turns-negative-on-restaurant-brands-international\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210738\" data-ts=\"1474895593\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210738-premarket-gainers-losers-of-9-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:10 am</a></h4><ul> <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ARRY' title='Array BioPharma Inc.'>ARRY</a> <font color='green'>+28%</font>. <a href='https://seekingalpha.com/symbol/CHMT' title='Chemtura Corporation'>CHMT</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/LPCN' title='Lipocine Inc.'>LPCN</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/GBR' title='New Concept Energy, Inc.'>GBR</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/GWPH' title='GW Pharmaceuticals plc'>GWPH</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/ZYNE' title='Zynerba Pharmaceuticals'>ZYNE</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/FATE' title='Fate Therapeutics, Inc.'>FATE</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/SBH' title='Sally Beauty Holdings, Inc.'>SBH</a> <font color='green'>+6%</font>.</li> <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/PTIE' title='Pain Therapeutics'>PTIE</a> <font color='red'>-64%</font>. <a href='https://seekingalpha.com/symbol/DRRX' title='Durect Corporation'>DRRX</a> <font color='red'>-28%</font>. <a href='https://seekingalpha.com/symbol/HIMX' title='Himax Technologies, Inc.'>HIMX</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/CALM' title='Cal-Maine Foods, Inc.'>CALM</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/BLRX' title='BioLineRx Ltd.'>BLRX</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/ACIA' title='Acacia Communications'>ACIA</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/DB' title='Deutsche Bank AG'>DB</a> <font color='red'>-6%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3210738\" data-linked=\"Premarket Gainers / Losers as of 9:10 am\" data-tweet=\"$ARRY $CHMT $LPCN - Premarket Gainers / Losers as of 9:10 am https://seekingalpha.com/news/3210738-premarket-gainers-losers-of-9-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3210738-premarket-gainers-losers-of-9-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210734\" data-ts=\"1474895113\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MAR\" target=\"_blank\">MAR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210734-morgan-stanley-likes-marriott-over-hyatt\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley likes Marriott over Hyatt</a></h4><ul> <li>Morgan Stanley upgrades Marriott International (NYSE:<a href=\"https://seekingalpha.com/symbol/MAR\" title=\"Marriott International, Inc.\">MAR</a>) to an Overweight rating from Equalweight.</li> <li>The investment firm takes a zero sum approach to the sector by <a href=\"http://www.streetinsider.com/Downgrades/Morgan+Stanley+Downgrades+Hyatt+Hotels+%28H%29+to+Underweight/12068881.html\" target=\"_blank\">sliding</a> Hyatt Hotels (NYSE:<a href=\"https://seekingalpha.com/symbol/H\" title=\"Hyatt Hotels Corporation\">H</a>) to Underweight from Equalweight and assigning a price target of $46.</li> <li>The fresh ratings from MS on the hotel operators is its first take since Marriott and Starwood closed on their mega-merger.</li> <li>MAR <font color=\"green\">+1.23%</font> premarket to $69.28.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3210734\" data-linked=\"Morgan Stanley likes Marriott over Hyatt\" data-tweet=\"$MAR $MAR $H - Morgan Stanley likes Marriott over Hyatt https://seekingalpha.com/news/3210734-morgan-stanley-likes-marriott-over-hyatt?source=tweet\" data-url=\"https://seekingalpha.com/news/3210734-morgan-stanley-likes-marriott-over-hyatt\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210731\" data-ts=\"1474894649\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210731-deutsche-bank-tumble-leads-europe-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche Bank tumble leads Europe lower</a></h4><ul>\n<li>Deutsche Bank is<font color=\"red\"> lower by 6%</font> after a German media report said Angela Merkel <a href=\"http://www.marketwatch.com/story/european-stocks-face-worst-day-in-almost-3-months-as-oil-deutsche-bank-shares-slump-2016-09-26\" target=\"_blank\">would not support</a> a bailout for the struggling lender (having provided bailout upon bailout for Greece, it's hard to believe Berlin wouldn't come to the aid of its largest lender).</li>\n<li>The Stoxx 50 (NYSEARCA:<a href=\"https://seekingalpha.com/symbol/FEZ\" title=\"SPDR EURO STOXX 50 ETF\">FEZ</a>) is<font color=\"red\"> lower by 1.4%</font>, led by a <font color=\"red\">1.65% decline</font> for Germnay's Dax (NYSEARCA:<a href=\"https://seekingalpha.com/symbol/EWG\" title=\"iShares MSCI Germany ETF\">EWG</a>). Should the Stoxx 50 decline hold, it would be the worst performance for the gauge since early July.</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/VGK\" title=\"Vanguard FTSE Europe ETF\">VGK</a>, <a href=\"https://seekingalpha.com/symbol/HEDJ\" title=\"WisdomTree Europe Hedged Equity ETF\">HEDJ</a>, <a href=\"https://seekingalpha.com/symbol/FEZ\" title=\"SPDR EURO STOXX 50 ETF\">FEZ</a>, <a href=\"https://seekingalpha.com/symbol/IEV\" title=\"iShares Europe ETF\">IEV</a>, <a href=\"https://seekingalpha.com/symbol/EPV\" title=\"ProShares UltraShort FTSE Europe ETF\">EPV</a>, <a href=\"https://seekingalpha.com/symbol/EZU\" title=\"iShares MSCI Eurozone ETF\">EZU</a>, <a href=\"https://seekingalpha.com/symbol/FEU\" title=\"SPDR STOXX Europe 50 ETF\">FEU</a>, <a href=\"https://seekingalpha.com/symbol/EURL\" title=\"Direxion Daily FTSE Europe Bull 3x Shares ETF\">EURL</a>, <a href=\"https://seekingalpha.com/symbol/DBEU\" title=\"Deutsche X-trackers MSCI Europe Hedged Equity ETF\">DBEU</a>, <a href=\"https://seekingalpha.com/symbol/EEA\" title=\"European Equity Fund\">EEA</a>, <a href=\"https://seekingalpha.com/symbol/FEP\" title=\"First Trust Europe AlphaDEX ETF\">FEP</a>, <a href=\"https://seekingalpha.com/symbol/HEZU\" title=\"iShares Currency Hedged MSCI EMU ETF\">HEZU</a>, <a href=\"https://seekingalpha.com/symbol/UPV\" title=\"ProShares Ultra FTSE Europe ETF\">UPV</a>, <a href=\"https://seekingalpha.com/symbol/IEUR\" title=\"iShares Core MSCI Europe ETF\">IEUR</a>, <a href=\"https://seekingalpha.com/symbol/FEEU\" title=\"Barclays ETN+ FI Enhanced Europe 50 ETN\">FEEU</a>, <a href=\"https://seekingalpha.com/symbol/ADRU\" title=\"BLDRS Europe 100 ADR Index ETF\">ADRU</a>, <a href=\"https://seekingalpha.com/symbol/FIEU\" title=\"Credit Suisse FI Enhanced Europe 50 ETN\">FIEU</a>, <a href=\"https://seekingalpha.com/symbol/DBEZ\" title=\"Deutsche X-trackers MSCI EMU Hedged Equity ETF\">DBEZ</a>, <a href=\"https://seekingalpha.com/symbol/FEUZ\" title=\"First Trust Eurozone AlphaDex ETF\">FEUZ</a>, <a href=\"https://seekingalpha.com/symbol/SBEU\" title=\"ETFS Diversified-Factor Developed Europe Index ETF\">SBEU</a>, <a href=\"https://seekingalpha.com/symbol/HFEZ\" title=\"SPDR Euro Stoxx 50 Currency Hedged ETF\">HFEZ</a>, <a href=\"https://seekingalpha.com/symbol/HFXE\" title=\"IQ 50 Percent Hedged FTSE Europe ETF\">HFXE</a>, <a href=\"https://seekingalpha.com/symbol/DEZU\" title=\"iShares Adaptive Currency Hedged MSCI Eurozone ETF\">DEZU</a>, <a href=\"https://seekingalpha.com/symbol/FIEE\" title=\"UBS AG FI Enhanced Europe 50 ETN\">FIEE</a>, <a href=\"https://seekingalpha.com/symbol/GSEU\" title=\"Goldman Sachs ActiveBeta Europe Equity ETF\">GSEU</a>, <a href=\"https://seekingalpha.com/symbol/HGEU\" title=\"ProShares Hedged FTSE Europe ETF\">HGEU</a>, <a href=\"https://seekingalpha.com/symbol/PTEU\" title=\"Pacer Trendpilo European Index ETF\">PTEU</a>, <a href=\"https://seekingalpha.com/symbol/RFEU\" title=\"First Trust RiverFront Dynamic Europe ETF\">RFEU</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210731\" data-linked=\"Deutsche Bank tumble leads Europe lower\" data-tweet=\"$FEZ $EWG $VGK - Deutsche Bank tumble leads Europe lower https://seekingalpha.com/news/3210731-deutsche-bank-tumble-leads-europe-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3210731-deutsche-bank-tumble-leads-europe-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210730\" data-ts=\"1474894597\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TGT\" target=\"_blank\">TGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210730-chief-digital-officer-target-steps-down\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chief digital officer at Target steps down</a></h4><ul> <li>Target (NYSE:<a href=\"https://seekingalpha.com/symbol/TGT\" title=\"Target Corporation\">TGT</a>) announces the <a href=\"http://www.cnbc.com/2016/09/26/targets-chief-digital-officer-leaves-company.html\" target=\"_blank\">departure</a> of its chief digital officer.</li> <li>Jason Goldberger steps down after four years on the job amid a reset of the e-commerce team.</li> <li>The company says Chief Information Officer Mike McNamara and Chief Merchandising Officer Mike Tritton will take over Goldberger's duties.</li>\n<li>Online sales at Target have been growing at a pace below its ambitious goal of 40% or better.</li> <li>TGT <font color=\"green\">+0.33%</font> premarket to $69.00</li> </ul><div class=\"tiny-share-widget\" data-id=\"3210730\" data-linked=\"Chief digital officer at Target steps down\" data-tweet=\"$TGT - Chief digital officer at Target steps down https://seekingalpha.com/news/3210730-chief-digital-officer-target-steps-down?source=tweet\" data-url=\"https://seekingalpha.com/news/3210730-chief-digital-officer-target-steps-down\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210727\" data-ts=\"1474893507\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LPCN\" target=\"_blank\">LPCN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210727-lipocines-next-gen-oral-testosterone-replacement-therapy-candidate-successful-in-mid-stage\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lipocine&#39;s next gen oral testosterone replacement therapy candidate successful in mid-stage study; shares up 28% premarket</a></h4><ul>\n<li>Thinly traded nano cap Lipocine (NASDAQ:<a href=\"https://seekingalpha.com/symbol/LPCN\" title=\"Lipocine Inc.\">LPCN</a>) moves up <font color=\"green\">28%</font> premarket, albeit on only 700 shares, in response to its announcement of positive results from a Phase 2b study of its oral testosterone replacement therapy candidate LPCN 1111.</li>\n<li>The open-label, two-period, multi-dose pharmacokinetic study randomized 60 hypogonadal males into five treatment groups of 12 subjects each. All were treated for 14 days with single and multiple doses of LPCN 1111. The primary objective, in addition to safety and tolerability, was to determine the Phase 3 dose, which met the primary and secondary endpoints.</li>\n<li>The value proposition of <a href=\"http://www.lipocine.com/pipeline/lpcn-1111/\" target=\"_blank\">LPCN 1111</a>, a novel ester prodrug of testosterone, is better patient compliance via once-daily oral dosing and the avoidance of the unwanted transfer of testosterone associated with topical treatments.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210727\" data-linked=\"Lipocine&#39;s next gen oral testosterone replacement therapy candidate successful in mid-stage study; shares up 28% premarket\" data-tweet=\"$LPCN - Lipocine&#39;s next gen oral testosterone replacement therapy candidate successful in mid-stage study; shares up 28% premarket https://seekingalpha.com/news/3210727-lipocines-next-gen-oral-testosterone-replacement-therapy-candidate-successful-in-mid-stage?source=tweet\" data-url=\"https://seekingalpha.com/news/3210727-lipocines-next-gen-oral-testosterone-replacement-therapy-candidate-successful-in-mid-stage\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210707\" data-ts=\"1474890545\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWTR\" target=\"_blank\">TWTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210707-no-deal-and-opco-downgrade-hit-twitter-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">No deal and OpCo downgrade hit Twitter premarket</a></h4><ul>\n<li>Noting lagging mobile growth, decreasing engagement, competitors investing more money in adtech, and a now-greater valuation, <a href=\"https://twitter.com/carlquintanilla/status/780370995903401985\" target=\"_blank\">Oppenheimer downgrades</a> Twitter (NYSE:<a href=\"https://seekingalpha.com/symbol/TWTR\" title=\"Twitter, Inc.\">TWTR</a>) to Underperform.</li>\n<li>The team says Twitter saw no boost to engagement from the Olympics - disappointing as the platform appeared to be well-positioned to take advantage of this type of event. The NFL experiment is also off to a slow start.</li>\n<li>Shares <font color=\"red\">-2.35%</font> premarket</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210707\" data-linked=\"No deal and OpCo downgrade hit Twitter premarket\" data-tweet=\"$TWTR - No deal and OpCo downgrade hit Twitter premarket https://seekingalpha.com/news/3210707-no-deal-and-opco-downgrade-hit-twitter-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3210707-no-deal-and-opco-downgrade-hit-twitter-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>35&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210700\" data-ts=\"1474889119\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PFE\" target=\"_blank\">PFE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210700-pfizer-opts-to-remain-one-company-shares-off-1-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pfizer opts to remain one company; shares off 1% premarket</a></h4><ul>\n<li>After what it calls an \"extensive evaluation\" to assess the feasibility and potential to maximize shareholder value by splitting into two publicly traded companies, Pfizer Innovative Health and Pfizer Essential Health, Pfizer (NYSE:<a href=\"https://seekingalpha.com/symbol/PFE\" title=\"Pfizer Inc.\">PFE</a>) decides to stay the course with its current corporate structure.</li>\n<li>Chairman &amp; CEO Ian Read says, \"With this decision, our two distinct businesses will remain separately managed units with Pfizer, which we believe is currently the best structure to continue to deliver on our commitments to patients, physicians, payers and governments, and to drive value for our shareholders. We believe that by operating two separate and autonomous units within Pfizer we are already accessing many of the potential benefits of a split - sharper focus, increased accountability and a greater sense of urgency - while also retaining the operational strength, efficiency and financial flexibility of operating as a single company as compared with operating as two, separate publicly traded companies. We will continue to generate the financial information necessary to preserve our option to split our business should factors materially change at some point in the future.\"</li>\n<li>EVP, Business Operations and CFO Frank D'Amelio adds, \"When we first explored the trapped value question several years ago, market valuations of other companies suggested that our two businesses could potentially be worth more as separate companies than they are together in a single company. However, over time, any potential gap between Pfizer's market valuation and an implied Sum of the Parts market valuation has closed. In our analysis, we concluded that splitting into two companies at this time would not enhance the cash flow generation and competitive positioning of the businesses  and the operational disruption, increased costs of a split and inability to realize any incremental tax efficiencies would likely be value destructive.\"</li>\n<li>The company reaffirms its financial guidance issued on August 2.</li>\n<li>Shares are down <font color=\"red\">1%</font> premarket on light volume.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210700\" data-linked=\"Pfizer opts to remain one company; shares off 1% premarket\" data-tweet=\"$PFE - Pfizer opts to remain one company; shares off 1% premarket https://seekingalpha.com/news/3210700-pfizer-opts-to-remain-one-company-shares-off-1-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3210700-pfizer-opts-to-remain-one-company-shares-off-1-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210698\" data-ts=\"1474888854\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HYMLF\" target=\"_blank\">HYMLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210698-labor-strikes-hit-hyundai-plants-in-south-korea\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Labor strikes hit Hyundai plants in South Korea</a></h4><ul> <li>An union representing Hyundai (<a href=\"https://seekingalpha.com/symbol/HYMLF\" title=\"Hyundai Motor Co., Ltd.\">OTCPK:HYMLF</a>) workers in South Korea <a href=\"http://www.wsj.com/articles/hyundai-workers-on-full-strike-for-first-time-in-12-years-1474855718\" target=\"_blank\">launched</a> its first national strike in a dozen years today after wage negotiations broke down.</li> <li>The workers have plans for partial strikes throughout the week.</li> <li>The lost output from the labor action is expected to impact Hyundai's second half profit.</li> <li>Shares of Hyundai fell about 1.1% in Seoul trading.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3210698\" data-linked=\"Labor strikes hit Hyundai plants in South Korea\" data-tweet=\"$HYMLF - Labor strikes hit Hyundai plants in South Korea https://seekingalpha.com/news/3210698-labor-strikes-hit-hyundai-plants-in-south-korea?source=tweet\" data-url=\"https://seekingalpha.com/news/3210698-labor-strikes-hit-hyundai-plants-in-south-korea\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210695\" data-ts=\"1474888179\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LYG\" target=\"_blank\">LYG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210695-lloyds-cut-to-sell-goldman\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lloyds cut to Sell at Goldman</a></h4><ul>\n<li>Saying the current valuation <a href=\"http://thefly.com/landingPageNews.php?id=2435369&amp;headline=LYG-Lloyds-Banking-rating-change-at-Goldman\" target=\"_blank\">doesn't price in</a> future margin headwinds, Goldman Sachs downgrades Lloygs (NYSE:<a href=\"https://seekingalpha.com/symbol/LYG\" title=\"Lloyds Banking Group plc\">LYG</a>) to Sell from Neutral.</li>\n<li>Shares are <font color=\"red\">down 3.7% </font>premarket.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210695\" data-linked=\"Lloyds cut to Sell at Goldman\" data-tweet=\"$LYG - Lloyds cut to Sell at Goldman https://seekingalpha.com/news/3210695-lloyds-cut-to-sell-goldman?source=tweet\" data-url=\"https://seekingalpha.com/news/3210695-lloyds-cut-to-sell-goldman\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210693\" data-ts=\"1474887630\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210693-futures-follow-global-markets-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Futures follow global markets lower</a></h4><ul>\n<li>Major Asian markets were <font color=\"red\">down more than 1%</font> overnight and Europe is <font color=\"red\">lower by 1.5%</font> at midday. The Dow leads U.S. stock index futures lower with a <font color=\"red\">0.7% decline</font>. The Nasdaq 100 is <font color=\"red\">off 0.6%</font>, and the S&amp;P 500 <font color=\"red\">0.5%</font>.</li>\n<li>Government bond yields continue to pull back, with the 10-year Treasury down 1.5 basis points to 1.60%. Gold is down marginally, and oil is <font color=\"green\">higher by 1.25%</font> to $45.02.</li>\n<li>New home sales for August are set to be released at 10 ET.</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/SPY\" title=\"SPDR S&amp;P 500 Trust ETF\">SPY</a>, <a href=\"https://seekingalpha.com/symbol/QQQ\" title=\"PowerShares QQQ Trust ETF\">QQQ</a>, <a href=\"https://seekingalpha.com/symbol/DIA\" title=\"SPDR Dow Jones Industrial Average ETF\">DIA</a>, <a href=\"https://seekingalpha.com/symbol/SH\" title=\"ProShares Short S&amp;P 500 ETF\">SH</a>, <a href=\"https://seekingalpha.com/symbol/SSO\" title=\"ProShares Ultra S&amp;P 500 ETF\">SSO</a>, <a href=\"https://seekingalpha.com/symbol/VOO\" title=\"Vanguard S&amp;P 500 ETF\">VOO</a>, <a href=\"https://seekingalpha.com/symbol/SDS\" title=\"ProShares UltraShort S&amp;P 500 ETF\">SDS</a>, <a href=\"https://seekingalpha.com/symbol/IVV\" title=\"iShares Core S&amp;P 500 ETF\">IVV</a>, <a href=\"https://seekingalpha.com/symbol/SPXU\" title=\"ProShares UltraPro Short S&amp;P 500 ETF\">SPXU</a>, <a href=\"https://seekingalpha.com/symbol/TQQQ\" title=\"ProShares UltraPro QQQ ETF\">TQQQ</a>, <a href=\"https://seekingalpha.com/symbol/UPRO\" title=\"ProShares UltraPro S&amp;P 500 ETF\">UPRO</a>, <a href=\"https://seekingalpha.com/symbol/PSQ\" title=\"ProShares Short QQQ ETF\">PSQ</a>, <a href=\"https://seekingalpha.com/symbol/SPXL\" title=\"Direxion Daily S&amp;P 500 Bull 3x Shares ETF\">SPXL</a>, <a href=\"https://seekingalpha.com/symbol/RSP\" title=\"Guggenheim S&amp;P 500 Equal Weight ETF\">RSP</a>, <a href=\"https://seekingalpha.com/symbol/SPXS\" title=\"Direxion Daily S&amp;P 500 Bear 3x Shares ETF\">SPXS</a>, <a href=\"https://seekingalpha.com/symbol/SQQQ\" title=\"ProShares UltraPro Short QQQ ETF\">SQQQ</a>, <a href=\"https://seekingalpha.com/symbol/QID\" title=\"ProShares UltraShort QQQ ETF\">QID</a>, <a href=\"https://seekingalpha.com/symbol/DOG\" title=\"ProShares Short Dow 30 ETF\">DOG</a>, <a href=\"https://seekingalpha.com/symbol/QLD\" title=\"ProShares Ultra QQQ ETF\">QLD</a>, <a href=\"https://seekingalpha.com/symbol/DXD\" title=\"ProShares UltraShort Dow30 ETF\">DXD</a>, <a href=\"https://seekingalpha.com/symbol/UDOW\" title=\"ProShares UltraPro Dow 30 ETF\">UDOW</a>, <a href=\"https://seekingalpha.com/symbol/RWL\" title=\"RevenueShares Large Cap ETF\">RWL</a>, <a href=\"https://seekingalpha.com/symbol/SDOW\" title=\"ProShares UltraPro Short Dow 30 ETF\">SDOW</a>, <a href=\"https://seekingalpha.com/symbol/VFINX\" title=\"Vanguard 500 Index Fund Inv\">VFINX</a>, <a href=\"https://seekingalpha.com/symbol/EPS\" title=\"WisdomTree Earnings 500 ETF\">EPS</a>, <a href=\"https://seekingalpha.com/symbol/DDM\" title=\"ProShares Ultra Dow 30 ETF\">DDM</a>, <a href=\"https://seekingalpha.com/symbol/QQEW\" title=\"First Trust NASDAQ-100 Equal Weight Index ETF\">QQEW</a>, <a href=\"https://seekingalpha.com/symbol/BXUB\" title=\"Barclays Capital Long B Leveraged Exchange Traded Notes Linked to the S&amp;P 500® Total Return Index\">BXUB</a>, <a href=\"https://seekingalpha.com/symbol/QQQE\" title=\"Direxion NASDAQ-100 Equal Weighted Index Shares ETF\">QQQE</a>, <a href=\"https://seekingalpha.com/symbol/SPLX\" title=\"UBS ETRACS Monthly Reset 2xLeveraged S&amp;P 500 total Return ETN\">SPLX</a>, <a href=\"https://seekingalpha.com/symbol/SFLA\" title=\"iPath Long Extended 3x S&amp;P 500 Index TR Index ETN\">SFLA</a>, <a href=\"https://seekingalpha.com/symbol/BXUC\" title=\"Barclays Capital Long C Leveraged Exchange Traded Notes Linked to the S&amp;P 500® Total Return Index\">BXUC</a>, <a href=\"https://seekingalpha.com/symbol/QQXT\" title=\"First Trust Nasdaq-100 Ex-Tech Sector Index ETF\">QQXT</a>, <a href=\"https://seekingalpha.com/symbol/SPUU\" title=\"Direxion Daily S&amp;P 500 Bull 2x Shares ETF\">SPUU</a>, <a href=\"https://seekingalpha.com/symbol/SPXE\" title=\"ProShares S&amp;P 500 Ex-Energy ETF\">SPXE</a>, <a href=\"https://seekingalpha.com/symbol/LLSP\" title=\"Direxion Daily S&amp;P 500 Bull 1.25X Shares\">LLSP</a>, <a href=\"https://seekingalpha.com/symbol/UDPIX\" title=\"ProFunds Ultra Dow 30 ProFund Inv\">UDPIX</a>, <a href=\"https://seekingalpha.com/symbol/OTPIX\" title=\"ProFunds NASDAQ-100 Fund Inv\">OTPIX</a>, <a href=\"https://seekingalpha.com/symbol/RYARX\" title=\"Rydex Inverse S&amp;P 500® Strategy Fund A\">RYARX</a>, <a href=\"https://seekingalpha.com/symbol/SPXN\" title=\"ProShares S&amp;P 500 Ex-Financial ETF\">SPXN</a>, <a href=\"https://seekingalpha.com/symbol/SPDN\" title=\"Direxion Daily S&amp;P 500 Bear 1x Shares ETF\">SPDN</a>, <a href=\"https://seekingalpha.com/symbol/SPXT\" title=\"ProShares S&amp;P 500 Ex-Technology ETF\">SPXT</a>, <a href=\"https://seekingalpha.com/symbol/SPXV\" title=\"ProShares S&amp;P 500 Ex-Health Care ETF\">SPXV</a>, <a href=\"https://seekingalpha.com/symbol/TALL\" title=\"RBC S&amp;P 500 Trend Allocator Index ETN\">TALL</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210693\" data-linked=\"Futures follow global markets lower\" data-tweet=\"$SPY $QQQ $DIA - Futures follow global markets lower https://seekingalpha.com/news/3210693-futures-follow-global-markets-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3210693-futures-follow-global-markets-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":53,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}